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REGULATION OF BIOFILM AND ANTIBIOTIC-RESISTANCE BY THE 
 
MODULATOR OF SarA (MSA) IN STAPHYLOCOCCUS AUREUS 
 




 Staphylococcus aureus is an important human pathogen that is the causative agent 
of life-threatening diseases such as endocarditis and osteomyelitis. The ability of S. 
aureus to thrive as a successful pathogen can be partially attributed to its ability to form 
biofilm. Biofilm is an extracellular polysaccharide, protein, and DNA-based slime layer 
that protects the bacterial community. The global regulator sarA is essential for biofilm 
formation. Since the modulator of sarA (msa) gene regulates several virulence factors and 
is required for the full expression of sarA, the capacity of the msa mutant to form a 
biofilm was examined. The mutation of msa results in reduced expression of sarA, and 
the msa mutant formed a weak and unstable biofilm. The msa mutant is able to adhere to 
surfaces and begins to form biofilm, but fails to mature indicating that the defect of the 
msa mutant biofilm is in the accumulation stage but not in primary adhesion. This finding 
is significant because it identifies a new gene that plays a role in the development of 
biofilm. 
 Antibiotic resistance in Staphylococcus aureus has become an issue of paramount 
importance as the rate of MRSA (Methicillin-Resistant Staphylococcus aureus)-related 
deaths have surpassed HIV-related deaths in the United States over the last decade. In 
this study, mutation of the msa gene leads to increased susceptibility (MIC 3 g/ml) to 




analysis was utilized to identify the genes that were differentially expressed. Apart from 
the fem genes, genes such as aux14, sigB, mecA, murAB and mraY were all differentially 
expressed in the msa mutant in comparison to the wild type strain COL. Additional 
functional assays and TEM studies show that the bacterial cell wall is compromised upon 
mutation of msa. The results from this study collectively indicated that msa plays an 
important role in antibiotic resistance by regulating cell wall and cell wall-precursor 
synthesis. Given these results and the possibility that Msa is a membrane protein, it is 
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Staphylococcus aureus: A Formidable Opponent 
   
Identification, Morphology, and Colonization  
Staphylococcus aureus is a Gram-positive eubacterium species that belongs to the 
phylum Firmicutes, class Bacilli, order Bacillales, family Staphylococcaceae and genus 
Staphylococcus. S. aureus is an important human pathogen that was the number one 
cause of nosocomial infections in the U.S. with 19,000 deaths in 2005—more than the 
number of deaths caused by HIV (78). Tremendous amount of resources have been 
devoted to understand the molecular and genetic factors that provide this pathogen with a 
clear advantage over the countless control and treatment measures devised through 
modern technology. It is clear that an in-depth understanding of S. aureus—from the in 
vivo pathogen population level to the molecular basis of host-pathogen interaction to the 
complex global regulatory networks—is necessary to successfully mitigate the medical, 
social and financial burden caused by this versatile and deadly bacterium. 
In 1878, Robert Koch observed the presence of Gram-positive cocci with the 
manifestation of various diseases. However, not until 1882 did Sir Alexander Ogston, a 
Scottish surgeon, named the organism as Staphylococcus. This was based on his previous 
observations in 1880 that a “cluster forming cocci” was the cause of abscess in humans. 
In deed, Staphylococcus aureus gets its name from the Greek word staphyle, which 
means bunch of grapes and coccus which means grain or berry (Figure 1.1). In 1884, 
Rosenbach differentiated Staphylococcus aureus from other cocci on the basis of colony 
pigmentation. The more virulent species formed colonies with a golden pigment (thus the 
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name aureus, a derivative of the Latin word ‘aurum,’ which means gold), whereas the 







Figure 1.1. Representative images of Staphylococcus aureus as visualized with different 
microscopy techniques. Characteristic clumping behavior is evident in these images.  
SEM image (right) photo credit: Janice Carr, Centers for Disease Control and Prevention.  
 
Staphylococci are 0.7-1.2 m in diameter, growing most rapidly under aerobic 
conditions in the presence of CO2. However, S. aureus is also capable of survival in 
environments with very low concentrations of oxygen as well (for example, growth 
within a biofilm) (33). The versatility of the pathogen is evident in the fact that 
staphylococci can also tolerate high amounts of salt in the growth medium (from 7.5-10% 
of NaCl) (57). Additionally, staphylococci can grow in a wide pH range (4.8 to 9.4) and 
even at very high temperatures (60°C for a short duration).  
Colonization with S. aureus occurs during the childhood years and is carried 
throughout one’s life. S. aureus is primarily found in relative abundance in the anterior 
nares, the throat and the perineum (red squares in Figure 1.2). Other secondary sites of 
prevalence include the hands, the gastrointestinal tract, the vagina and the axillae (blue 
circles in Figure 1.2). The fact that S. aureus is present in the nasal passage of 32.4% of 
individuals in the U.S. population (55), combined with the increasing prevalence of 
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Methicillin-Resistant Staphylococcus aureus (MRSA) strains world-wide (77, 114), 
makes S. aureus a formidable pathogen that confounds healthcare workers and 
researchers alike. In fact, the rate of hospital-acquired staphylococcal infections caused 
by MRSA strains rose from 2% in 1974 to 64% in 2004, resulting in 126,000 
hospitalizations in the U.S. (85) and S. aureus-related aggregate healthcare costs up to 1 
billion dollars (110). The problem has been compounded further with a steady rise in 
outpatient cases manifesting MRSA infections. (142)  With community-acquired MRSA 
infections (CA-MRSA) rapidly catching up with the more expected and somewhat 
understood hospital-acquired MRSA infections (HA-MRSA) (139), it is imperative that 
new therapeutic solutions are found for this rapidly evolving pathogen. 
 
 
Figure 1.2. Staphylococcus aureus primary and secondary colonization sites. 
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 Infections Caused by S. aureus  
Staphylococcus aureus is a multifaceted pathogen that can cause a wide array of 
infections that range from the common skin abscesses to the more serious and life-
threatening conditions such as endocarditis (inflammation arising from vegetative 
colonization of the heart valve tissue) and osteomyelitis (infections of the bone) (92). 
Other serious life-threatening conditions caused by S. aureus include but are not limited 
to Staphylococcus aureus bacteremia (SAB) (156), Staphylococcus aureus infective 
endocarditis (SAIE) (46), surgical-site infections (1), device-related infections (implants, 
catheters, etc.) (2), skin and soft tissue infections (100), spine and brain abscesses (131),  
ocular diseases (6), staphylococcal pneumonia (80), urinary tract infections (153), toxic 
shock syndrome and toxin-mediated syndromes (37, 92) (Figure 1.3). S. aureus is able to 
cause these infections by successfully utilizing a plethora of virulence factors. These 
virulence factors (potential therapeutic targets) are often redundant and/or variable across 
different strains, making it even harder to formulate effective prophylactic or 
immunological therapies.  However, steady strides are being made in understanding the 
molecular basis of staphylococcal infections that will help toward development of 




Figure 1.3. Staphylococcus aureus can cause a wide array of infections at various sites on 
the human body.  It can range from skin abscesses to life-threatening infections such as 




Figure 1.4. Representative images of staphylococcal infections leading to A. Infective 
Endocarditis1 and B. Osteomyelitis2. Heart and bone tissue have been degraded due to the 
infection.  
 
1Image Credit: Michigan State University, College of Veterinary Medicine. Web link:http://cvm.msu.edu/pare/Docs/endocarditisB.jpg 




Antibiotic Resistance in Staphylococci 
Methicillin-Resistant Staphylococcus aureus (MRSA)  
Treating staphylococcal infections have become increasingly difficult owing to 
the sharp increase in MRSA strains over the last few decades. As stated earlier, rise in 
CA-MRSA cases, especially, are of great concern because these types of infections are 
manifested in younger, otherwise healthy individuals who have not been recently 
hospitalized.  CA-MRSA strains generally cause skin and soft-tissue infections spreading 
from skin-to-skin contact with infected individuals. Interestingly, HA-MRSA is resistant 
to multiple types of antibiotics whereas CA-MRSA is typically highly resistant only to -
lactams and a few other classes of antibiotics (109). 
This antibiotic profile is partly due to the presence of various resistance genes that 
are located in the mobile genetic element called staphylococcal cassette chromosome mec 
(SCCmec). The SCCmec carries the mecA gene that encodes for the alternate penicillin-
binding protein 2a (PBP2a). Apart from mecA, its regulatory genes (mecR1 and mecI) 
and other insertion sequences are generally found on the SCCmec. (65). To date there are 
VIII SCCmec types that range from 21 kb to more than 64 kb (81, 162) (Figure 1.5). With 
a considerable degree of variability between the SCCmec types, the origin of this mobile 
genetic element is still unclear. It is postulated that S. aureus could have possibly 
obtained SCCmec from S. epidermidis via horizontal gene transfer (5, 61). Whatever the 
origins may be, SCCmec, along with other mechanisms, confers S. aureus with the 
invincibility to resist most antibiotics available today. Additional details regarding 
















Figure 1.5. Schematic of SCCmec types identified thus far in Methicillin Resistant 
Staphylococcus aureus. All types share the common mecA element but contain varying 
combinations of Tn (transposon) and IS (insertion sequences) elements, and Highly-
Variable Regions (HVR). 
 
Staphylococci and Biofilm 
Biofilm and Antibiotic Resistance 
The ability of S. aureus to resist antibiotics is further intensified by the fact that it 
takes 10 to 1000 times more antibiotics to inhibit the growth of cells within a biofilm 
(67). Biofilm is a self-produced extracellular polysaccharide, protein and eDNA matrix 
(62, 122, 140) that encloses the bacterial community and provides it with protection from 
environmental factors and antibiotics (140). As a result of this protection, S. aureus in a 
biofilm is exposed to sub-inhibitory concentrations of the antibiotic that not only helps in 
promoting antibiotic resistance but also induces biofilm formation (66). In addition to the 
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physical barrier provided by the biofilm, it has been proposed that cells growing within a 
biofilm are resistant to antibiotics due to the fact that these cells grow slower in 
comparison to exponential-phase bacteria in a planktonic growth condition (4).  This 
notion is further strengthened by studies that have shown that biofilm is more resistant to 
beta-lactam antibiotics in comparison to other non-cell wall targeting antibiotics such as 
minocycline and tigecycline (104).  Beta-lactam activity is dependent on a rapidly 
growing cell population with an active cell-wall turnover.  
Of all growth conditions and physiological states studied, probably the most 
clinically significant is staphylococci growth within a biofilm. Bacteria in biofilms 
exhibit recalcitrance to antimicrobial compounds and persistence in spite of sustained 
host defenses (59). Several factors can induce biofilm formation. Exposure to fluctuations 
in glucose availability, osmotic stress, ethanol and certain antibiotics can all trigger 
differential gene expression that leads to the bacterial community switching from a 
planktonic state of growth to a biofilm state of growth (11, 88, 124). Staphylococcal 
biofilms form generally in three distinct stages (Figure 1.6.): (1) primary adhesion to 
surfaces by means of adhesins or cell wall components, (2) accumulation of multilayered 
clusters of cells via the production of a polysaccharide, and (3) detachment and 





Figure 1.6. Stages of Biofilm Formation. Source: Image adapted from Center for Biofilm 
Engineering website: biofilm.montana.edu  
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If biofilm formation and maintenance is in fact a highly regulated process, as 
evidenced by the existing data in the literature and conclusions drawn by experts in the 
field, it is imperative that a solid communication system should exist in order to precisely 
coordinate the expression of various genes in response to environmental or genetic 
signals. Staphylococci effectively employ such a system called quorum sensing based on 
cell density in its immediate environment. 
Quorum sensing is achieved by detecting chemical signals (autoinducing 
peptides) produced and secreted by the cells in the vicinity.  When the cell density 
exceeds past a certain threshold, the cells are able to “perceive” the quantitative build-up 
of neighboring cells and initiate changes in gene expression. Quorum sensing was first 
observed in 1993 in Vibrio fischeri (8) and since then has been shown to be prevalent 
among various Gram-positive and Gram-negative bacterium as a mode of inter-species 
and intra-species communication (7, 48). Staphylococci possess two quorum-sensing 
systems that have been studied extensively (82). The agr system, which along with the 
Staphylococcal accessory regulator (sar) are major players involved in global gene 
regulation in Staphylococcus aureus.  Understanding the current knowledge regarding 
these two systems will help understand how they possibly interact with the msa 
(modulator of sarA) gene.   
Global Regulators: Agr and SarA 
Accessory Gene Regulator (agr) System  
The agr quorum sensing system (Figure 1.7.), which is also responsible for 
regulating virulence, is made up of two divergent promoters, P2 and P3 that encode for 
RNAII and RNAIII, respectively. The RNAII transcript includes the agrACDB locus 
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which encodes for an autoinducing peptide (AIP) that is secreted to the outside 
environment and is sensed by a response regulator system that directly acts to control the 
expression of various genes at the transcriptional level. Specifically, AgrA and AgrC 
make up the response regulator and membrane sensor, respectively. AgrC detects the AIP 
that is encoded by agrD. AgrB, which is embedded in the membrane, processes and 
exports the AIP outside of the cell.  The sensing of AIP by AgrC sets in motion a set of 
phosphorylation events that activates the AgrA response regulator and induces 
transcription from both P2 and P3 promoters. There are four different types of agr locus, 
categorized based on the ability of AIP from one group to activate or inhibit AgrC from 
another group (74, 75).  AIP from S. epidermidis strongly inhibits S. aureus AgrC 
belonging to agr type I, II and III, but not type IV. In contrast to healthy individuals, 
where agr locus type distribution is relatively even, patients with chronic wounds or in-
dwelling devices, agr locus type I is the most commonly seen group (52). It is possible 
that one type of agr locus might interfere with other agr sensing systems to give itself a 




Figure 1.7. Schematic of the Agr quorum sensing system involved in virulence 
regulation.  
 
The RNAIII transcript, transcribed from the P3 promoter, spans the hld gene, 
which encodes for the -toxin (73). The agr system’s regulatory effects via the RNAIII 
transcript is functional regardless of the production of -toxin (72, 112, 154).The 
regulation of virulence factor expression by the Agr system has been extensively studied 
in vitro. RNAIII upregulates the production of the -toxin (Hla) (105) and downregulates 
the production of surface protein A (Spa). RNAIII also indirectly regulates the production 
of virulence factors through its action on other regulators such as rot (repressor of toxins) 
(128).  The overall regulatory effect of RNAIII is characterized by the increased 
production of exoproteins (hla, hlb, hld, hlgCB, tst, sspABC, splABDF, aur, scp, seb, sec, 
sed, eta, etb, geh, plc, lip, nuc, sak, cap, fame, scn, lukPV) and decreased production of 
surface-associated proteins (111, 119).  
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Expression of agr has also been associated with a reduced capacity to form a 
biofilm in both S. aureus and S. epidermidis (53, 82). Strains that produced high levels of 
RNAIII, such as RN6390, show an increase in biofilm when agr is mutated (10). It is 
believed that the negative effect of agr on biofilm is most likely due to the surfactant 
effects of the -toxin encoded by the hld gene and not RNAIII itself (151).  This is 
supported by the observation made by Yarwood et al. (160) that agr might be part of a 
dispersal system during the detachment stage of biofilm formation. Although mutation of 
agr increases biofilm in vitro, several studies in animal models have shown that agr 
mutant in vivo has reduced virulence (3, 16, 23, 51, 98, 102).  Given that in vivo 
conditions could expose the agr mutant to several host- or infection-specific variables; it 
is possible to envision a sophisticated agr system that regulates the expression of genes 
necessary for biofilm formation and virulence depending on the situation at hand. In fact, 
studies comparing CA-MRSA and HA-MRSA strains have shown that there is an 
increased level of agr in the former (154). Additionally, there was an increase in the 
production on phenol-soluble modulins (PSMs), which are positively regulated by agr 
and have been attributed as the reason for increased virulence seen with CA-MRSA 
strains (154). PSMs, a total of seven in S. aureus, function as chemoattractants and have 
proinflammatory properties (87, 114). Mutation of PSMs, although not all, have led to 
decreased virulence in a murine bacteremia model (154). Collectively, this indicates that 
the agr system may be controlling the expression of two distinct phenotypes in vivo—
biofilm formation and toxin production—each, proving to be advantageous at the 




Staphylococcal accessory regulator A (sarA) 
The agr system, apart from autoinduction, is controlled by several other 
regulatory factors that modulate the expression of virulence gene either through agr or 
independent of agr. One such gene that was discovered in 1992 is the Staphylococcal 
accessory regulator (sar; later renamed to sarA as more homologues were discovered) 
(24). SarA has been shown to bind the intergenic region between the agr P2 and P3 
promoters (26, 63, 106, 123). It is believed that SarA binding activates the transcription 
of agr and that this accounts in large part for the impact of sarA on expression of S. 
aureus virulence factors. Mutation of sarA in the 8325-4 strain RN450 and RN6390 was 
found to limit expression of agr and a number of agr-regulated genes, particularly under 
microaerophilic growth conditions (22, 27).  
The sarA locus encodes three overlapping transcripts, all which share a common 
terminus and include the sarA gene (9). These transcripts have been designated sarA 
(0.56 kb), sarC (0.8 kb), and sarB (1.2 kb), with the corresponding promoters designated 
P1, P2 and P3, respectively (97). The sarA and sarB transcripts are produced 
preferentially during the exponential growth phase while the sarC transcript is produced 
preferentially during the post-exponential growth phase (97).  
SarA and its homologs are dimeric winged helix DNA-binding proteins. Each of 
the monomers contain five -helices, three -strands and several loops ( 1 2- 1 3 4-
2 3- 5). Within each winged helix motif is a helix-turn-helix motif (bold) and a -
hairpin turn wing (underlined), both of which are putative DNA binding domains. SarA 
and its homologs (n = 11) belong to the SarA protein family. Within this grouping, these 
proteins are further divided into 3 sub-families: 1. single-domain proteins, 2. two-domain 
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proteins and 3. MarR homologs (25). SarS, SarY and SarU belong to the two-domain 
protein sub-family; SarA, SarR, SarV, SarT, SarX and Rot belong to the single-domain 
sub-family; and SarZ and MgrA belong to the MarR homolog sub-family. These proteins 
and their functions have been summarized in Table 1.1.  Several mechanisms of 
regulation by the SarA protein family have been proposed (25), however, from the 
protein structure studies performed by Liu et al., (90) the initial steps of regulation appear 
to be established when the major groove of the target DNA is bound by the helix-turn-
helix region and the minor groove is bound by the winged region. 
Genomic DNA analysis has shown that these SarA homologs are also present in 
other clinically important Staphylococcus species such as S. epidermidis, S. 
saprophyticus, and S. hemolyticus (25). Although the exact virulence genes and 
mechanism might differ from species to species, the presence of these homologs is 
significant in narrowing down meaningful targets for therapy.   
Table 1.1  
SarA Protein Family and Its Functions 
Gene Locus Possible Function 
mgrA SA0641 MarR homolog; A regulator of autolysis and agr (also called rat or 
norR) 
rot SA1583 A repressor of toxin synthesis, opposite to agr 
sarA SA0573 Activates genes via agr and agr independent pathways 
sarR SA2089 A negative regulator of sarA and positive activator of agr 
sarS SA0108 An activator of protein A synthesis 
sarT SA2286 An activator of sarS and a repressor of alpha hemolysin synthesis 
sarU SA2287 A positive regulator of agr 
sarV SA2062 A regulator of autolysis repressed by SarA and MgrA 
sarX SA0623 A negative regulator of agr and activated by MgrA 
sarY SA2091 Function Unknown 




SarA is necessary for the transcription of the ica operon, but it is not known 
whether it directly or indirectly activates ica transcription since the typical SarA binding 
sequence upstream of virulence genes is not found upstream of ica (60, 150). The 
staphylococcal accessory regulator, sarA, is a major global regulator that is essential for 
biofilm formation both in vitro and in vivo (10, 150). Additionally, O'Neill et al. (113) 
showed that sarA is essential for biofilm formation in both MRSA and MSSA. However 
the mechanism of sarA regulation of biofilm is not yet understood.  





 BACKGROUND RELEVANT TO THIS STUDY 
The Modulator of SarA (msa) Gene 
Msa Regulates Expression of SarA 
In 2006, Sambanthamoorthy et al. (130) showed that the msa (modulator of sarA) 
gene regulates the expression of various virulence factors either through sarA or 
independently of sarA.  As stated earlier, SarA is a global regulator that controls the 
expression of over 100 virulence genes and other cellular processes. However, evidence 
from previous studies suggested that there may exist accessory elements that control the 
expression of sarA and/or the function of SarA. For example, the mutation of sarA 
decreased the expression of agr but in an in vitro transcription system, purified SarA 
inhibited transcription from agr promoters (21). Also, SarA regulates gene expression in 
a temporal manner but SarA is present approximately at the same amounts throughout the 
growth cycle (15, 28, 97). This indicated the presence of an additional element(s) that is 
present within growing cells that augments SarA regulation. Indeed, these observations 
lead to the development of a luminescent reporter system (cna-luxABCDE) to screen for 
sarA-related defects in mutants generated by transposon mutagenesis in the RN6390 
background (130).  Mutants that showed a sarA-mutant-phenotype in a sarA-positive 
genotype were selected for further characterization. It was reported that the msa gene 
(SA1233) positively modulates the expression of sarA and regulates the expression of 




Figure 2.1. Msa regulates virulence factors via SarA or independent of SarA.   
 
 
Msa Regulates Several Virulence Factors 
Sambanthamoorthy et al. (130) have performed various phenotypic 
characterizations in order to fully understand the role of msa in S. aureus. Protease assay 
with the msa mutant showed an increase in proteolytic activity, similar to that of a sarA 
mutant in previous studies (14). Complementation with a good copy of msa on a plasmid 
vector restored protease levels back to wild type amounts. Hemolytic activity on the other 
hand was reduced in the msa mutant. Hemolytic activity was measured from post-
exponential growth phase (12 h) by using 1 % rabbit blood. Total hemolytic activity was 
reported as the percentage of activity relative to the parent strain, RN6390. Regulatory 
mutants sarA, agr and sarA/agr were included as controls. sarA mutant behaved similarly 
to that of the msa mutant.  
When tested for its ability to bind to host proteins, the msa mutant was unable to 
bind to fibronectin and fibrinogen. Results of fibronectin binding were consistent with the 
transcription studies done where fnbA expression was down in the msa mutant. However, 
clfA expression (virtually unchanged in comparison to wild type) did not correlate with 
the results from the fibrinogen-binding assay. The authors attributed this decrease in 
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fibrinogen-binding capacity to the increase in protease levels, as reported earlier by 
McAleese et al. (99). Mutation of msa enabled RN6390 to bind to collagen. Since 
RN6390 does not have the cna gene, strain UAMS-174 (a derivative of RN6390 with the 
cna gene inserted in the chromosome) was used for this assay. Complementation with a 
functional copy of msa restored collagen-binding to wild type levels. 
Msa, a Membrane Protein? 
Finally, sequence analysis of Msa indicated that it is a membrane protein with 
three transmembrane domains that contained phosphorylation and binding sites, which, 
suggests that Msa might interact with the external environment (108) (Figure 2.2). The 
authors of the study hypothesized that Msa acts as a sensor for an external signal that 
modulates sarA expression and thereby regulates the expression of S. aureus virulence 
factor (130). It should also be noted that according to this study, Msa appears to be highly 
conserved among different strains (RF122, MRSA252, MSSA476, MW2, COL, Mu50, 
N315, and NCTC 8325) of S. aureus based on both nucleotide and protein sequences 
(108). However, the authors were unable to find any known homologous proteins with 
high degree of significance, thus, making Msa a putative novel signal transducer protein. 
Studies are currently underway to validate the predicted Msa protein structure.  
Given the exciting possibility that Msa could be an unique interface between 
external signals and internal gene regulatory networks, the role of msa in cellular 
processes and global gene regulation was studied to gain further understanding into the 






Figure 2.2. Schematic of predicted Msa protein structure depicting three transmembrane 
domains, possible phosphorylation sites and signal peptide cleavage site. Adapted from 





MSA IS INVOLVED IN THE ACCUMULATION STAGE OF BIOFILM 
FORMATION IN STAPHYLOCOCCUS AUREUS 
Abstract 
 
Staphylococcus aureus is an important pathogen that forms biofilm. The global 
regulator sarA is essential for biofilm formation. Since the modulator of sarA (msa) is 
required for full expression of sarA and regulates several virulence factors, the capacity 
of the msa mutant to form a biofilm was examined. The mutation of msa results in 
reduced expression of sarA in biofilm and that the msa mutant formed a weak and 
unstable biofilm. The msa mutant is able to adhere to surfaces and begins to form biofilm 
but fails to mature indicating that the defect of the msa mutant biofilm is in the 
accumulation stage but not in primary adhesion. The msa gene plays an important role in 
biofilm development which is likely due to its role in modulating the expression of sarA. 
This finding is significant because it identifies a new gene that plays a role in the 
development of biofilm. 
Introduction 
Staphylococcus aureus is a gram-positive pathogen that causes potentially life 
threatening nosocomial- and community-acquired infections, such as osteomyelitis and 
endocarditis. An important characteristic of S. aureus is its ability to form a biofilm, a 
characteristic associated with several diseases (41). Bacteria in biofilm are encased in a 
polysaccharide glycocalyx (140), which provides them with protection against host 
defenses and antimicrobial drugs (140). Staphylococcal biofilm form in two distinct 
stages: (1) primary adhesion to surfaces by means of adhesins or cell wall components, 
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and (2) accumulation of multilayered clusters of cells via the production of a 
polysaccharide (32). Cells are also able to detach from the biofilm and disperse to distant 
sites for colonization or infection. Various genetic factors are also involved in regulating 
biofilm formation, maintenance and dissemination. Although much is known today, the 
mechanisms underlying complex regulatory networks that fine-tune the biofilm 
phenotype are yet to be uncovered by the research community. 
Biofilm Genetics  
There are various genetic factors that regulate the expression of genes necessary 
to initiate and sustain a biofilm state of growth.  The irreversible adherence of free-
floating planktonic cells to a to host tissue or other surfaces is facilitated by surface 
adhesins called microbial surface components recognizing adhesive matrix molecules 
(MSCRAMMs) (45). The MSCRAMMs are made up of the collagen-binding protein 
Cna, Fibronectin-binding proteins, FnbA and FnbB, and the fibrinogen-binding proteins 
clumping factor A and clumping factor B, ClfA and ClfB. These molecules bind to 
collagen, fibronectin and fibrinogen in the host tissue (45).  Once the cells get established 
over a surface, intercellular adhesins such as poly-N-acetylglucosamine (PNAG), S. 
aureus surface protein G (SasG), accumulation and adhesion-associated protein (Aap) 
and biofilm-associated protein (Bap) are expressed in order to facilitate cell-to-cell 
adhesion and maturation of the biofilm (30, 93, 96, 126). Transcription of these genes and 
biofilm formation in response to environmental or genetic cues is controlled by global 
regulators such as SarA, SigB, MgrA (60, 123, 145) and other as-of-yet unidentified or 
uncharacterized factors.  Although a lot of research has been conducted to understand the 
components of a biofilm and the regulators that sculpt its formation and dissemination, 
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we have only scratched the surface in understanding this complex mode of growth 
coordinated by the bacterial community.  
The ica locus, which encodes for IcaA, IcaC, IcaD and IcaB, is one of the well 
studied biofilm components that is necessary for the synthesis of PIA/PNAG in S. aureus 
and S. epidermidis. The membrane protein IcaA together with IcaD (to achieve maximum 
enzyme efficiency) function as an N-acetyglucosaminyltransferase to catalyze the 
production of 10-20mers of N-acetylglucosamine from UDP-N-acetylglucosamine. N-
acetylglucosamine oligomers longer than 20-mer are synthesized and exported out of the 
cell with the help of IcaC (54, 56). Outside the cell, IcaB, a secreted protein, acts as a 
deacetylase that optimally (approximately 2-8%) deacetylates amino acid groups from the 
synthesized oligomer which aids in bacterial aggregation and biofilm formation (96). The 
icaADBC operon is negatively regulated by the transcriptional repressor protein IcaR 
(intercellular adhesin regulator). 
In 2007, Rohde et al. (127), showed that factors other than polysaccharides were 
involved in biofilm formation.  Since then, proteinaceous biofilm adhesins such as Bap, 
SasG, Aap, and AtlE (an autolysin) have all been shown to play a role in the biofilm 
phenotype.  Of importance is the possibility that these proteins could be specific to 
certain strain or even to certain staphylococci species. For example, Bap is a necessary 
intercellular adhesin that has so far only been identified in bovine mastitis isolates and is 
not implicated in isolates causing infections in humans (34). Another example is the Aap 
protein, which has significant homology to the SasG protein, has been identified in S. 
epidermidis strains (30, 134).  AtlE, a 148 kDa protein, is involved in initial attachment 
and accumulation during biofilm formation. Also, AtlE was implicated in the 
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accumulation of extracellular DNA (eDNA). It is speculated that DNA might be released 
by the autolytic action of AtlE and eDNA could possibly contribute to the stability in the 
complex architecture of a mature biofilm (62, 122). 
The staphylococcal accessory regulator sarA is a major global regulator that is 
essential for biofilm formation both in vitro and in vivo (10, 11, 150). Beenken  et al. 
(2003) reported that the mutation of sarA reduced biofilm formation in six of the eight 
clinical strains they tested (UAMS-1, UAMS-601, SA113, SC-01, S6C, and DB) (10). 
Around the same time, a similar study by Valle et al., also found that SarA is essential for 
biofilm formation in Staphylococcus aureus (150). Of interest, O'Neill et al. (113) 
showed that sarA is essential for biofilm formation in both MRSA and MSSA. However 
the mechanism of sarA regulation of biofilm is not yet understood.  
Previously the msa gene was identified as a positive modulator of sarA (130). We 
also showed that mutation of msa resulted in differential expression of several virulence 
factors (130). These findings prompted the present study, focused on the role of msa in 
biofilm formation. Based on these previous observation that sarA mutants in several 
strains are unable to form a biofilm (10, 150), and the fact that msa modulates the 
expression of sarA (130), the msa mutant’s capacity to form biofilm in MRSA strain 
COL was tested. From various genetic and phenotypic evidence presented in this study, it 
is proposed that the msa gene is indeed involved in modulating the accumulation of 






Materials and Methods 
Bacterial Strains, Plasmids, and Growth Conditions 
Biofilm-forming S. aureus strain COL was chosen for study because it forms a 
biofilm in vitro and is virulent in animal models of endocarditis (71, 125). Strains were 
grown on tryptic soy agar (TSA) or in tryptic soy broth (TSB) at 37°C under constant 
aeration, supplemented with antibiotics whenever appropriate. The media used in flow 
cells and microtiter plate assays were TSB supplemented with 3% sodium chloride and 
0.5% glucose. These conditions have been shown previously to promote good biofilm 
growth (10). 
Phage Farming and Transduction 
Generalized transduction with phage 11 was utilized to generate an msa mutant 
and a complemented msa mutant in the COL strain.  A phage lysate was prepared by 
overlaying TSA plates with TOP Agar (3 grams of TSB, 0.7 grams of Bacto™ Agar, 100 
ml dH20, autoclaved and cooled to 50°C before use) containing 100 l of cells from a 
moderately-thick (1/4th of a plate) suspension of the donor strain, 100 l of phage (10-fold 
serial dilutions, from -1 to -5) and 40 l of 500mM CaCl2.  The plates were incubated 
overnight at room temperature. The next day, the plate with the least amount of phage 
and the most clearing was harvested and the suspension was filter-sterilized using a 
0.2 m filter. A 100 l aliquot was plated on a TSA plate to test for sterility of the lysate. 
To perform the transduction, 500 l of recipient-strain cells (from a very heavy 
suspension; full plate of cells into 2ml of medium) was added to 500 l of the prepared 
phage lysate in 1ml of TSB containing 20 l of 500 mM CaCl2. The mixture was then 
incubated at 37°C with vigorous shaking for exactly 20 minutes. At the end of 20 
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minutes, 1ml of ice-cold 0.02M sodium citrate was added and the tube was placed on ice. 
Cell pellets were collected by centrifugation and the pellets were resuspended in 500 l 
of 0.02M sodium citrate before being plated onto TSA plates containing selective 
medium and 500 g/ml of sodium citrate. Colonies that appeared on these plates were re-
streaked and screened using PCR and/or restriction digestion.   
Biofilm Assay 
 Biofilm assays were performed in microtiter plates and flow cells, as described 
previously (10, 11), in order to study static biofilm conditions and biofilm conditions 
under shear stress, respectively. 
Microtiter plate biofilm assay. The biofilm forming capacity of the wild-type 
COL strain, the msa mutant, and the complemented msa mutant were examined by 
microtiter plate assay. A standard 96-well microtiter plate biofilm assay was conducted as 
follow: Overnight cultures were diluted 1:200 into TSB supplemented with 0.5% glucose 
and 3.0% sodium chloride. Samples (200 μl) were transferred into the wells of a 96-well 
polystyrene microtiter plate (Corning, Inc., Corning, NY). These wells were pre-coated 
for 24 h at 4°C with 20% human plasma diluted in carbonate buffer (pH 9.6). After 
incubating the innoculated plates without shaking at 37°C for 24 h, the wells were gently 
washed twice with 200 μl of phosphate-buffered saline to remove non-adherent cells. 
Adherent biofilm were then fixed with 200 μl of 100% ethanol prior to staining for 2 min 
with 200 μl of 0.41% (wt/vol) crystal violet in 12% ethanol (Protocol Crystal Violet; 
Biochemical Sciences, Swedesboro, NJ). The stain was aspirated, and the wells were 
washed three times with phosphate-buffered saline. A quantitative assessment of biofilm 
formation was obtained by adding 100 μl of 100% ethanol and incubating at room 
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temperature for 10 min. A total of 50 μl of the eluate was transferred to a sterile 
polystyrene microtiter plate, and the absorbance at 595nm was determined using a 
Synergy2™ Multi-Mode Microplate Reader (BioTek Instruments, Inc., Winooski, VT). 
Flow-cell biofilm assay. The microtiter plate assay is a very quick and high-
throughput way to screen for biofilm defects; however, due to the technically tedious 
nature of this assay employing several washes with PBS, it was possible that the biofilm 
could have been dislodged before staining. Therefore, in addition to the microtiter plate 
assay, a more robust system of biofilm formation was used. Specifically, the flow-cell 
biofilm device was used to study the role of msa in biofilm formation.  Flow-cell device 
(Stovall Life Sciences, Greensboro, NC) is a once-flow-through system that pumps a 
constant flow of growth medium at a steady rate using a peristaltic pump over a 1mm x 
1mm x 4mm plastic chamber where the biofilm growth occurs. This type of device 
closely mimics the environmental conditions experienced by cells in a biofilm state of 
growth. 
The device was pre-coated with human plasma. A suspension of bacteria from an 
overnight culture of the respective strains was then introduced into the flow cell channels 
by injection and allowed to incubate at 37°C for one hour. Enriched media (TSB 
containing 3% sodium chloride and 0.5% glucose) was pumped through the flow cells at 
a flow rate of 0.5 ml/min. Flow cells were observed and photographed periodically. No 
antibiotic selection was used when growing the complemented msa mutant in biofilm. 
Adherence Assay  
Two adherence assays were used to measure the capacity of the msa mutant to 
bind surfaces with or without pre-coating with plasma. 
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  Microtitire plate assay. The first adherence assay was performed by modifying 
the microtiter biofilm assay described above. Briefly, overnight cultures of S. aureus test 
strains were diluted to an OD560
 of 0.1 in fresh TSB, and 200 l was added to each well 
(polystyrene pre-coated with human plasma) in triplicate. Following one hour incubation 
at 37°C, the microtiter wells were washed three times with 1X PBS. Adherent cells were 
fixed with 200 l of 100% ethanol for 10 min. Ethanol was discarded and the wells were 
allowed to be air dried for 2 min. Adherent cells were then stained for 2 minutes with 200 
l of 0.41% Crystal Violet (w/v in 12% ethanol), then washed three times with 1X PBS. 
Again, the wells were allowed to dry, and then ethanol was used to elute the crystal violet 
from the wells. Absorbance readings were taken at 595 nm using a Synergy2™ Multi-
Mode Microplate Reader (BioTek Instruments, Inc., Winooski, VT). An average of data 
collected from three independent experiments is reported.  
Catheter adherence assay. The second assay measures adherence to a catheter 
without pre-coating with plasma. This assay was performed as previously described by 
McKenny et al. (101). Briefly, staphylococcal strains were grown overnight in TSB and 
cultures were standardized to an OD650 of 0.1. Catheters (PE10; Becton Dickinson and 
Co., Sparks, MD), 0.5 cm in length were placed into appropriate cultures. After 
incubating the cultures at 37°C for 30 min, the catheters were removed using sterile 
forceps and washed five times in sterile PBS. After washing, the catheters were placed in 
1% proteose peptone (Difco, Ann Arbor, MI) and continuously vortexed for two minutes 
to release bacterial cells from the catheter. Serial dilutions were plated onto TSA plates in 
order to enumerate the bacteria. The mean and standard errors were calculated for the 
adherence of each strain. 
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Confocal Microscopy  
Confocal scanning laser microscopy was performed using a Carl-Zeiss LSM 510 
META with excitation at 488 nm and emission collected at 500 to 530 nm (green 
channel). Image stacks of the biofilm were taken from at least three distinct regions on 
the flow cell and analyzed using the provided software (Carl-Zeiss, Inc., Peabody, MA). 
Thickness of the biofilm was measured starting from the z-section at the flow-cell/biofilm 
interface to the z-section at the top of the biofilm surface containing < 5% of total 
biomass. 
Cell Collection and RNA Isolation 
 Total RNA was isolated from S. aureus planktonic cultures using Qiagen RNeasy 
Mini column (Qiagen) as previously described (130), based on a method developed by 
Lindsay and Foster (89). S. aureus cultures were grown without antibiotic selection and 
under low-aeration conditions (150 r.p.m. at a media volume:flask volume ratio of 0.5). 
Cells were harvested at optical densities (OD560) of 0.3, 1.5 and 4.0, which correspond to 
the mid-exponential, late-exponential, and post-exponential growth phases, respectively. 
Isolation RNA from biofilms was accomplished by harvesting cells from flow cells as 
previously described (10) and using Qiagen RNeasy Mini column. The optional on-
column RNase-free DNase I (Qiagen) was used to remove contaminating DNA. After 
isolation of RNA, traces of contaminating DNA were further eliminated by treating RNA 
samples with RNase-free DNase I (DNA-free kit, Ambion) and incubating at 37°C for 
20 min. Samples were used immediately or stored at –80°C. The quality, integrity and 
concentration of the RNA were determined by using an Agilent 2100 Bioanalyzer 
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(Agilent Technologies, Santa Clara, CA) as described by the manufacturer. An average of 
data collected from three independent experiments is reported. 
Real-Time Quantitative PCR 
The primers that are used for real-time quantitative PCR (qPCR) were designed 
with Primer3 software (Massachusetts Institute of Technology) to amplify gene fragments 
with an optimal size of 75–100 bp. The fragment of the gene of interest was cloned into 
plasmid pCR2.1 TOPO to determine PCR efficiency. Specifically, the plasmid was 
isolated and a series of 10-fold dilutions were prepared corresponding to 500,000 to 5 
plasmid copies. For each primer set, a standard curve was generated to determine the 
correlation coefficient as an indicator of PCR efficiency. All RT-qPCR reactions were run 
in triplicate. Melting curve analysis and agarose gel electrophoresis was done to verify 
primer set specificity.  
Measurements of relative levels of gene expression were done by RT-qPCR. Total 
RNA was reverse transcribed into cDNA using iScript cDNA synthesis kit (Bio-Rad). 
The reverse transcriptase reactions were done at 25°C for 5 min, 42°C for 30 min and 
85°C for 5 min. cDNA was stored at –20°C until needed. PCR reactions were done in 
25 μl reactions by using iQ SYBR Green Supermix (Bio-Rad) as recommended by the 
manufacturer (Bio-Rad). The reaction mixtures contained: 5 μl cDNA; 12.5 μl iQ SYBR 
Green Supermix; 0.5 μl forward primer (1.5 pmol μl–1); 0.5 μl reverse primer 
(1.5 pmol μl–1); and 6.5 μl de-ionized H2O. PCR amplification was done using an iCycler 
(Bio-Rad) and the amplification parameters were as follows: 94°C for 3 min, 1 cycle at 
95°C for 3 min, 40 cycles at 95°C for 30 s, 50°C for 30 s and 72°C for 1 min. The final 80 
cycles began at 55°C and were increased by 0.5°C every 10 s. All RT-qPCR reactions 
30 
 
were done in triplicate and the mean CT was used for analysis of results. To verify the 
absence of contaminating DNA, each RT-qPCR experiment included controls that lacked 
template cDNA or reverse transcriptase. The constitutively expressed gene for gyrase 
(gyr) was used as an endogenous control as described previously (54). Analysis of 
expression of each gene was done based on at least two independent experiments. 
Twofold or higher changes in gene expression were considered significant. 
Results and Discussion 
Prior studies have shown that the modulator of sarA gene (msa) is required for 
full expression of sarA, which in turn is essential for biofilm formation (10, 130, 150). To 
examine the role of msa in biofilm formation, a msa mutant was generated in the 
methicillin-resistant S. aureus (MRSA) strain COL. S. aureus COL was chosen for study 
because it forms a biofilm in vitro and is virulent in animal models of endocarditis (71, 
125). The msa mutation was confirmed, and its effect on sarA, by measuring transcription 
levels of msa and sarA in the wild-type COL strain, the msa mutant, and the 
complemented msa mutant by real-time quantitative PCR (RT-qPCR). As expected, the 
msa mutant showed no detectable expression of msa in planktonic cultures or biofilm 
(Table 3.1). Additionally, transcription of sarA was reduced at least five-fold in these 
cultures in both planktonic cultures and biofilm (Table 3.1). These results are consistent 
with finding from the previous study (130) and show that msa is a positive modulator of 







Relative Expression of msa and sarA in the msa Mutant 
  Biofilm Planktonic 






msa vs. COL Compl. vs. COL 
Gene Function mature (12 hrs) mid late post mid late post 
msa modulator of sarA 0.002 1.15 <0.001 <0.001 <0.001 0.95 0.57 0.88 
sarA 
Staphylococcal 
accessory regulator A 
0.30 0.77 0.22 0.21 0.12 0.76 0.78 0.48 
 
Note. Gene expression of msa and sarA in the msa mutant or the complemented mutant (Compl.) relative to wild-type (COL). Values 
represent the mean ratio of three independent experiments. Expression measurements were done in biofilm and three planktonic 
growth phases (mid-exponential, late-exponential and post-exponential). 
 
Reduced Biofilm Formation in the msa Mutant 
 Biofilm formation was observed at 6, 12, and 24 h post-inoculation in the wild-
type COL strain and the complemented msa mutant microtiter plates. Conversely, there 
was no evidence of biofilm formation for the msa mutant at 6 or 12 h post-inoculation 
(Figure 3.1). At 24 hours post-inoculation, the msa mutant formed a biofilm that appeared 
similar to that of the wild-type COL strain. These results were reproduced at least three 
times and were confirmed in subsequent experiments, suggesting that the msa mutant has 








Figure 3.1. Biofilm formation in the msa mutant in microtiter plates. The wild type strain 
COL, the msa mutant and the complemented msa mutant were grown in TSB 
supplemented with NaCl and glucose. Cultures were incubated for 6, 12 and 24 hours in 
the wells of microtiter plates with pre-coating with plasma proteins. The violet staining is 
an indication of biofilm formation in the wells.   
  
 
Figure 3.2. Biofilm was quantified by staining with crystal violet and elution with 
ethanol as described in Materials and Methods section. All values have been normalized 
to wild type levels which were arbitrarily set as 100%. 
 
msa Mutant has Defective Biofilm under Flow Conditions  
The results in Figure 3.1. clearly show that the msa mutant forms a weak or 
defective biofilm up to 12 hours post inoculation. To isolate the biofilm formation stage 
at which the defect is manifested—initial attachment stage, cell-to-cell adhesion and 
accumulation stage or the detachment stage—a flow-cell biofilm assay was performed. 
Wild-type COL strain and the complemented msa mutant formed robust and mature 










form a robust and uniform biofilm within the flow cell in the first 12 hours (Figure 3.3). 
The gross morphology of the partial biofilm formed by the msa mutant was similar to 
those formed by the wild type strain and the complemented mutant (Figure 3.3). 
However, while the biofilms formed by the wild-type and the complemented msa mutant 
persisted for up to 36 h before sloughing off, the biofilm formed by the msa mutant 
rapidly disintegrated (Figure 3.3). These results were confirmed in three independent 
experiments, indicating that the msa mutant is defective in its ability to form mature 
biofilms. 
 
Figure 3.3. Biofilm formation in the msa mutant in flow cells. The wild type strain COL, 
the msa mutant, and the complemented msa mutant were used to inoculate flow cells. 
TSB supplemented with NaCl and glucose was provided at a flow rate of 0.5 ml/minute. 
Biofilm formation was monitored for 36 hours. Arrow indicates the direction of flow of 
medium. 
 
msa Mutant Not Defective in Initial Attachment 
 
Two different adherence assays were used in order to determine if the msa biofilm 
defect was in the initial attachment stage of biofilm formation. A modified microtitre 
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plate biofilm assay, where cells are incubated only for an hour, showed that the msa 
mutant actually bound to the polystyrene surface at a significantly greater degree than the 
wild type strain COL or the complemented msa mutant strain (Figure 3.4, Panel A). 
Some strains of S. aureus require host proteins in order to adhere to the surface. In order 
to rule out any bias in adherence due to the cells’ interactions with host proteins in the 
human plasma, a catheter adherence assay was done without coating the catheters in 
human plasma. Again, the msa mutant adhered to a greater degree to the catheters than 
the wild type or the complemented msa mutant strains (Figure 3.4, Panel B).  
 
Figure 3.4. The msa mutant adheres to surfaces better than wild type. A. Catheter 
adherence assay done without human plasma. B. Modified microtitre-plate assay done 
with human plasma.  
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msa Mutant Grows Normally But Does Not Accumulate within Biofilm 
The possibility that the mutation of the msa gene causes a growth defect could 
explain the weak biofilm phenotype. Growth rates were measured for the wild-type 
strain, the msa mutant, and the complemented msa mutant in planktonic cultures in TSB. 
All three strains grew equally under normal growth conditions (Figure 3.5).  
Next, the rate of cell accumulation within the flow cell system was measured for 
the wild-type and msa mutant strains. In order to monitor cell deposition, plasmid 
pSB2019 (a constitutively expressed Gfp3a plasmid construct obtained from Dr. Phillip J. 
Hill; (121)) was introduced into the wild type COL and COL msa mutant strains. A Carl-
Zeiss LSM 510 META confocal laser scanning microscope with excitation at 488 nm and 
emission collected at 500 to 530 nm (green channel) was used to monitor biofilm 
formation at regular intervals. Consistent with the results from the adherence assays, 
there was no significant difference in initial adherence to the surface or formation of 
microcolonies between the msa mutant and the wild-type at 4 hours (Figure 3.6). 
However, Z-stack images of the biofilm at 6 hours (Figure 3.6) showed that the msa 
mutant cells were unable to accumulate and grow into a mature biofilm in comparison to 
the wild type. The wild type strain COL on the other hand was able to form a mature 
tower-like structure that is characteristic of a robust biofilm. This suggests that the msa 





Figure 3.5. Growth curve of the wild type strain COL, msa mutant and the complemented 




Figure 3.6. Z-stack images of the biofilm using confocal microscopy. Both the wild type 
strain COL and the msa mutant adhere to the flow-cell surface at 4 hours growth. At 6 
hours of growth, the msa mutant biofilm is unable to form mature tower-like structures 
(white arrow head) that are indicative of complex biofilm architecture.  
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In addition to sarA, differential gene expression analysis of several other genes 
known to be involved in biofilm formation was conducted using RT-qPCR. Fold change 
in gene expression of all tested genes is listed in Table 3.2. A change in expression level 
of twofold or higher was considered to be significant. 
Table 3.2 
 
Relative Gene Expression of Factors Involved in Biofilm Formation  
  
  Biofilm 
Gene Function msa vs. COL Compl. vs. COL 
fnbA fibronectin-binding protein 0.79 0.83 
clfA clumping factor A 0.16 0.68 
atl bifunctional autolysin 0.35 0.88 
alsS -acetolactate synthase 9.77 1.51 
arcA arginine deiminase < 0.001 0.56 
icaA intercellular adhesin 0.72 2.06 
spxA transcriptional-regulator 0.72 1.16 
tcaR transcription regulator 1.12 0.76 
 
Note. Genes known to be involved in biofilm formation and regulation were analyzed using RT-qPCR and their relative gene 
expression values were calculated using the delta-delta Ct method. Values presented here are an average of two independent runs 
comparing the msa mutant gene expression to the wild type strain COL and the complemented msa mutant is compared to the wild 
type strain COL.   
Some of these selected loci are regulated by sarA (alsS, atlA, and icaA); the others 
are not directly associated with the sarA regulon (arcA, spx, and tcaR). Expression levels 
of these genes were analyzed in biofilm using the wild-type strain COL, the msa mutant, 
and the complemented msa mutant. A change in expression level of twofold or higher 
was considered significant. 
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Mutation of msa resulted in a significant increase in alsS expression in biofilm. 
The alsSD operon encodes acetolactate synthase and an acetolactate decarboxylase. 
Previous studies have reported that mutation of the alsSD operon in S. aureus resulted in 
a biofilm defect (20, 159). The biofilm defect of the alsSD mutant was attributed to the 
role of this operon in the production of acetoin from pyruvate (84, 159). Acetoin 
production is necessary for acid tolerance within biofilms (11, 155). The effect of over-
expression of the alsSD operon as observed in the msa S. aureus mutant on biofilm 
formation is not clear. One might speculate that premature build up acetoin in the 
medium could signal exhaustion of glucose and lead to detachment of cells from biofilm. 
Further studies are needed to explore this possibility. 
Mutation of msa resulted in a significant decrease in expression of arcA in biofilm 
(Table 3.2). The arcA gene encodes arginine deiminase which is a member of the 
arginine deaminase (ADI) pathway. This pathway is used to generate energy using 
arginine under anaerobic conditions (36, 132). The results of several studies point to the 
importance of the ADI pathway in biofilm formation and pathogenesis. Some oral 
bacteria have been shown generate ammonia via the ADI pathway to maintain pH 
homeostasis in biofilms (19). Other studies have shown that the ADI pathway was 
induced during biofilm formation (11). Additionally, bacteria in biofilm selectively 
utilize six amino acids, including arginine (163), further demonstrating the importance of 
the ADI pathway in biofilm formation and pathogenesis and may explain the msa mutant 
biofilm phenotype. However, when arcD was disrupted in the S. aureus strain UAMS-1, 
the mutant formed effective biofilms and were as virulent as wild-type in a catheter 
infection mouse model despite the fact that PIA was significantly reduced (163). These 
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discrepant results may be due to differences in strains, growth conditions, or infection 
model but they clearly indicated the need for more studies in the role of arginine 
metabolism in biofilm development and pathogenesis. 
Biofilm accumulation relies on cell-cell adhesion mediated by the polysaccharide 
intercellular adhesin (PIA), which is produced by the icaADBC operon, and was shown to 
play a major role in biofilm accumulation (56). Recent studies, however, have indicated 
that the icaADBC operon is not essential for biofilm formation in some strains (11, 35, 
44, 143). We studied the expression levels of genes encoded by this operon and found 
that the msa mutation reduced the expression of icaA in the post-exponential growth 
phase of planktonic cultures only. In biofilm, however, the expression of icaA in the 
mutant was not significantly different from wild-type (Table 3.2). The ica-dependent 
pathway is primarily regulated by the icaR repressor (29). When IcaR becomes activated 
by Spx, PIA levels are reduced (47, 115). We found that there was no significant 
difference in expression of icaR or spx in the msa mutant compared to the wild-type. This 
is consistent with findings by Tu Quoc et al. (149) that some biofilm-defective mutants 
did not show altered PIA levels. Additionally, O'Neill et al. (113) recently showed that 
glucose-induced biofilm formation in MRSA strains is ica-independent. This is relevant 
to our data, since the COL strain is a MRSA strain and glucose was added to the culture 
media to induce biofilm in this study suggesting that msa is involved in biofilm formation 
using an ica-independent mechanism as was previously described in some strains (11, 30, 
122). Another important locus, sasG, which is similar to accumulation-associated protein 
in S. epidermidis has been shown to play a role in cell-cell adhesion and accumulation of 
biofilm (11, 30, 122), however, there was no change in expression of sasG between the 
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msa mutant and wild type grown in planktonic cultures as determined by DNA 
microarray experiments in our lab. 
Conclusions 
In summary, mutation of the msa gene in strain COL of S. aureus results in a 
weak biofilm at the accumulation stage resulting in an immature biofilm. This defect is 
likely mediated by the reduced expression of sarA in the msa mutant. Our results 
suggested that the weak/unstable biofilm defect in the msa mutant is an intermediate 
phenotype between the sarA mutant and wild-type. However, it cannot be ruled out that 
the contribution of other loci that fall under the influence of msa in a sarA-independent 
manner (e.g., arcA) could be responsible for this phenotype. Our findings emphasize the 
complex nature of biofilms and indicated that several independent regulators and 
environmental stimuli contribute to the establishment of sessile communities of S. 
aureus. The intermediate phenotype of the biofilm formed by the msa mutant is a helpful 
clue in deciphering the sarA-mediated mechanism of biofilm formation, which is still 
unclear. Sequence analysis shows that Msa is a putative membrane protein (108, 130) 
suggesting that it may play a role in environmental sensing that feeds into the sarA 





MSA PLAYS A CRITICAL ROLE IN THE REGULATION OF ANTIBIOTIC 




 Antibiotic resistance in Staphylococcus aureus has become an issue of paramount 
importance as the rate of MRSA (Methicillin-Resistant Staphylococcus aureus)-related 
deaths have surpassed HIV-related deaths in the United States over the last decade. S. 
aureus is the causative agent of life-threatening disease such as endocarditis and 
osteomyelitis. Resistance to B-lactams has been associated with several mechanisms 
including production of lactamases, expression of alternative penicillin-binding proteins 
(PBP) and global regulators. Further analysis of resistance mechanisms in MRSA, have 
now been expanded to include fem and aux-family of genes. The fem (factors essential in 
methicillin-resistance) and aux (provisionally named as auxiliary genes involved in 
methicillin-resistance) together comprise more than 35 genes that are involved in 
methicillin resistance. While the functions of some of these gene products are still 
unknown, a majority of these genes are involved in cell wall or cell-wall precursor 
synthesis. The modulator of SarA (msa) gene controls the expression of various genes 
either independently or via sarA. In this study, we show that mutation of the msa gene 
leads to increased susceptibility (MIC 3 g/ml) to methicillin and oxacillin in comparison 
to wild type MRSA strain COL (MIC 1600 g/ml). This effect was confirmed under 
biofilm growth conditions as well.  
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In order to define the role of msa in the antibiotic resistance mechanism, we 
analyzed the expression of several aux, fem, mur and pbp genes that are affected by 
mutation of msa using real time quantitative-PCR and DNA microarrays. Expression 
analysis showed that upon challenge with oxacillin, femA, femB, femX and femD (glmM) 
genes in the msa mutant were differentially expressed in comparison to wild type strain 
COL. FemABX are involved in forming the pentaglycine peptidoglycan cross-bridge in 
S. aureus; FemD is involved in synthesizing the precursors of UDP-MurNAc-
pentapeptide. Disruption of the fem genes has been shown to reduce or abolish methicillin 
resistance. Along with the fem genes such as aux14, sigB, mecA, murAB and mraY were 
all differentially expressed in the msa mutant in comparison to the wild type strain COL. 
Additionally, functional assays were done to further characterize the role of msa in 
regulating antibiotic resistance. The results from this study collectively indicated that msa 
plays an important role in regulating cell wall and cell wall precursor synthesis resulting 
in methicillin resistance.  
Introduction 
 
Antibiotic Resistance in Staphylococcus aureus 
 
S. aureus is now the leading cause of nosocomial infections. Slowly, community-
acquired MRSA (CA-MRSA) infections have also started to spread in the general, 
otherwise healthy population and have now become a serious medical issue that requires 
the collective efforts of researchers, clinicians, policy makers and the general public to 
bring it under control. With increasing efforts being invested into understanding CA-
MRSA strains, it is becoming clearer that the genetic background of a strain is more 
important in determining its virulence potential than the presence or absence of mec 
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elements. It is important now more than ever to find chromosomally encoded factors that 
confer MRSA strains with the ability to adapt against almost all antibiotics. 
Mechanisms Involved in Resistance 
Antibiotic resistance in Staphylococcus aureus has become an urgent national 
medical issue as the rate of infected MRSA cases have steadily increased over the last 
decade.  Various therapeutic agents, starting from -lactams such as Penicillin 
(introduced into clinical practice the 1940s; >95% resistance) to glycopeptides like 
Vancomycin (introduced in 1956; resistance rare in the U.S.), have already seen 
resistance in some region or the other around the world (69).  Various factors are 
involved in antibiotic resistance.  In the case of MRSA strains, antibiotic resistance is 
primarily mediated by the non-native mecA gene.  Pbp2a, the protein product of the mecA 
gene takes over as the major transpeptidase in building the peptidoglycan layer when 
challenged with a -lactam such as methicillin or oxacillin.  Pbp2, the native penicillin-
binding protein 2, has been shown to have a low level of activity in consensus with 
Pbp2a.  The other penicillin-binding proteins—Pbp1, Pbp3 and Pbp4—are inactivated in 
the presence of -lactams. Pbp2a and Pbp2 essentially maintain the peptidoglycan layer 
and enable the cell to survive even in the presence of inhibitory levels of antibiotics (86).  
Apart from the PBPs, other auxiliary factors are critical in the peptidoglycan layer 
maintenance and have been studied as possible targets for therapeutic agents (83). 
Consequent studies to understand antibiotic resistance mechanisms in S. aureus have led 
to the discovery of several other factors that are important for the MRSA resistance 
phenotype. In 1999, de Lencastre et al. (40) utilized random transposon mutagenesis and 
identified the existence of fem (factors essential for methicillin resistance) genes 
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necessary for -lactam resistance. Several studies have been conducted to identify the 
role of specific fem genes. In 2002, Berger-Bachi and Rohrer (12) identified several 
auxiliary factors involved in cell-wall precursor formation and turnover, regulation, 
transport, and signal transduction. These factors, it was concluded, could play an 
important role in the level of resistance exhibited by MRSA strains. 
Penicillin-Binding Proteins  
Methicillin-susceptible S. aureus (MSSA) strains carry three high-molecular-mass 
penicillin-binding proteins and one low-molecular-mass penicillin-binding protein. 
Collectively, these proteins are involved in the construction and cross-linking of the 
peptidoglycan layer. Pbp1 (85 kDa), present at approximately 185 copies per cell, is an 
essential PBP that is involved in cell division process (117, 120, 152). Pbp2 (81 kDa), 
present at 460 copies per cell, is a bifunctional PBP that conducts both transpeptidase and 
-lactam-insensitive transglycosylase activities (91, 120).  Penicillin-binding protein 3 
(75 kDa), present at 150 copies per cell, and the low-molecular-mass, 45 kDa Pbp4, 
present at 285 copies per cell are not essential for growth (76, 120, 158). Inactivation of 
Pbp3 did not cause any changes in the cell wall composition, nor did it affect the growth 
rate. It was concluded that Pbp1 might be taking over the role of Pbp3, thus accounting 
for the lack of phenotypic alterations (49, 118, 120). Recent studies, however, have 
shown that Pbp4 is essential for -lactam resistance in community-acquired MRSA 
strains. In fact, it was shown that in these strains, a functioning Pbp4 was necessary for 
the full expression Pbp2 when challenged with oxacillin (103). It is possible that this 
Pbp4 requirement could be specific to CA-MRSA strains.  
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MRSA strains on the other hand, express an additional PBP called Pbp2a that is 
encoded by the mecA gene. PBP2a has a lower affinity to -lactamase-resistant -lactams 
than the native PBP2.  It is believed that Staphylococcus sciuri may have been the source 
of Pbp2a, which, through horizontal gene transfer between staphylococci species may 
have entered into S. aureus (31). Pbp2a is a high molecular weight class B transpeptidase 
that catalyzes the formation of cross-bridges in bacterial peptidoglycan. Pbp2a requires 
two things when faced with the task of building the peptidoglycan layer, a) It requires a 
pentaglycine-decorated muramyl-pentapeptide precursor which depends on the integrity 
of intercellular cell-wall-building machinery that involves a number of auxiliary genes 
(fem genes: femA, femB, femC, femX) and b) It needs the transglycosidase activity of the 
PBP2 protein since PBP2a is only a transpeptidase (86). Either of the bla or mec 
regulatory proteins, BlaI and MecI, respectively, can control the production of PBP2a in 
staphylococci (137). -lactam binding to the extramembrane sensor of the signal 
transducers, BlaR1 or MecR1, leads to the autocleavage of the cytoplasmic domains of 
these molecules. This is followed by cleavage of the cognate repressor, BlaI or MecI, 
respectively and to the transcription of blaZ or mecA (161).  Several studies have 
concluded that the amount of Pbp2a does not correlate with the level of -lactam 
resistance exhibited by a strain (38). This suggested that there were chromosomal factors 
in addition to the SCCmec involved in high level methicillin resistance. The fact that 
methicillin resistance is inherently linked to the genetic background of a particular strain 
and its response to the environment was further evidenced by the changes in level of 
methicillin resistance to external conditions such as pH, osmolarity, temperature and 
growth medium (18, 94, 138). 
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fem and aux Genes  
Over the last decade, several genetic factors involved in high-level methicillin 
resistance have been identified and characterized using transposon mutagenesis (12, 40). 
de Lancastre et al., constructed a Tn551 transposon library in the highly and 
homogenously resistant MRSA strain COL. Insertional mutants that showed at least a 15-
fold decrease in MIC levels from wild type levels (1600 g/ml) were identified and 
sequenced producing over 20 new chromosomal factors involved in methicillin 
resistance. These genes were named factors essential for the expression of methicillin 
resistance or fem genes. The femA gene encodes for a 48 kDa protein that belongs to the 
FemABX family of nonribosomal peptidyl transfereases.  These three transferases are 
responsible for synthesizing the pentaglycine interpeptide bridge for the peptidoglycan 
layer. FemA, specifically, adds the 2nd and 3rd glycine to the pentapeptide interpeptide. 
An inactivated femAB, leads to the reduction of the interpeptide to a monoglycine, 
leading to a poorly cross-linked peptidoglycan.  In MRSA strains, methicillin-resistance 
is completely abolished upon inactivation of femA. (70)  The protein product of the femB 
gene is responsible for adding the 4th and 5th glycine to the pentapeptide interpeptide 
bridge.  Henze et al. showed that a transposon mutant of the femB gene exhibited 
increased levels of beta-lactam susceptibility in amounts comparable to a femA mutant 
(64). femX, also known as fmhB, is an essential gene that adds the first glycine to the 
pentapeptide interpeptide (148). The fact that these three gene products are critical in the 
proper cross-linking of the peptidoglycan layer, makes them an attractive 




Other Factors Involved in Resistance  
Several studies have contributed to a better understanding of additional factors 
involved in -lactam resistance. It is clear that the survival of S. aureus despite an 
onslaught of antibiotics is a testament to its highly complex and redundant regulatory 
mechanism.  A comprehensive list of chromosomal genes involved in -lactam resistance 
is listed in Table 4.1 below. Of importance are genes such as glmM (also known as 
femD), sigB, abcA, and ccpA. GlmM is a phosphoglucosamine mutase that converts 
glucosamine 6-phosphate to glucosamine 1-phosphate. This is the initial step in the 
production of UDP-N-acetylglucosamine, the nucleotide sugar that is involved in 
peptidoglycan synthesis. GlmM mutants exhibited a 5% decrease in peptidoglycan cross-
linking, however, did not adversely affect the fitness of S. aureus. This indicates that 
there may be alternative pathways to synthesize glucosamine 1-phosphate (53). SigB is a 
stress-response regulator that controls the expression of various virulence factors and 
global regulators (13). Wu et al. showed that upon inactivation of SigB there was a 
drastic reduction in methicillin resistance (from 1600 g/ml to 12 to 25 g/ml). The 
authors concluded that a functional stress-response system is essential in order for 
methicillin resistance to occur (157).  
AbcA is an ATP-dependent transporter that is involved in autolysis. Expression of 
abcA is induced by methicillin and is regulated by the agr system. Overexpression of 
abcA leads to enhanced methicillin resistance (133, 147). The carbon catabolite protein 
(CcpA), which is responsible for regulating glucose-specific carbon source utilization in 
S. aureus, was recently shown to be involved in regulation of virulence factors, biofilm 
formation and resistance to methicillin (135, 136). The inactivation of ccpA reduces 
48 
 
methicillin resistance (40). It is possible that the role of CcpA is a consequence of 
metabolic activity rather than deliberate regulation of virulence factors. 
Table 4.1 
 




Gene, Synonym  Gene description 
   
SA0104 norG 










yabJ-spoVG sigB-dependent regulatory operon 
SA0573 sarA Stapyhylococcal accessory regulator A 
SA0598 pbpD Penicillin-binding protein 4 
SA0599 abcA ATP-dependent transporter 
SA0614 graR 
SA0615 graS 
Two-component sensor transducer system 
SA0641 rat, mgrA Regulator of autolytic activity 
SA0702 llm, tagO 
Lipophilic protein,  
undecaprenyl-phosphate- -N-acetylglucoasminyl-1-
phosphate transferase 
SA0793 dlt operon D-Alanyl-lipoteichoic acid synthesis operon 
SA0876 murE UDP-N-actetyl tripeptide synthetase 
SA0909 fmtA UDP-N-acetylglucosamine transferase 
SA1075 hmrB, acpP Acylcarrier protein 
SA1149- 
1150 
glnRA Glutamine synthetase operon 
SA1193 mprF, fmtC Lysylphosphatidylglycerol synthetase 
SA1194 msrA2 Methionine sulfoxide reductase 
SA1195 msrR Membraen prtein with extracellular LytR-CpsA-Psr domain 
SA1206 femA Nonribosomal peptidyltransferase aminoacyltransferase  
SA1207 femB Nonribosomal peptidyltransferase aminoacyltransferase 
SA1249 sa1249 Hypothetical protein 
SA1283 pbpB Bifunctional transpeptidase-transglycosylase 
SA1458 lytH N-Acetyl-muramoyl amidase 
SA1557 ccpA Carbon catabolite control repressor 




Two-component sensor transducer system mediating the 
cell wall stress stimulon 
SAS065, 
SA1842-4 
agr operon Accessory gene regulator 




Table 4.1 (continued). 
   
Gene ID 
Number1 Gene, Synonym Gene description 
   
SA1886 murF UDP-N-acetylmuramyl-pentapeptide synthetase 
SA1935 hmrA Similar to amidase 




Cell envelope protein with LPXTG-motif, function uknown, 





SA2057 fmhB, femX Nonribosomal peptidyltransferase aminoacyltransferase 
SA2062 sarV Transcriptional regulator 
SA2329- 
SA2328 
cidA-cidB Holin-like protein 
SAS030 graF Protein with a bipartite nuclear targeting domain 
   
Note: 1Gene ID numbers correspond to those of the S. aureus N315 genome. Source: Table 8.1, “Resistance to -lactam Antibiotics,” 
p. 177-178. Staphylococci in Human Diseases. Eds. Kent B. Crossley et al., 2010. Wiley-Blackwell.    
Role of Msa in Antibiotic Resistance  
 Tortonda et al. recently reported on studies concerning the effect of cell-wall 
antibiotics on sarA and mgrA in the homogenously methicillin resistant strain COL (146). 
Although the sarA and mgrA single mutants showed a decrease in MIC, the sarA/mgrA 
double mutant was affected the most by oxacillin. This effect was also seen in in vivo 
studies using a rabbit endocarditis model. The authors of this study concluded that 
resistance to oxacillin is greater when both sarA and mgrA are present, i.e., sarA plays 
some role in resistance to oxacillin. Since Msa is suspected to be a putative membrane 
protein and the fact that it positively regulates SarA, it is possible that Msa could be 
sensing environmental signals (e.g., oxacillin) and affecting changes in gene expression 
along with sarA, a global regulator, to cope with the presence of antibiotics.  
 Following this reasoning, an oxacillin MIC assay was done with the wild type, 
homogenously resistant strain COL, its isogenic msa mutant and the complemented msa 
mutant. MIC of oxacillin was determined using the microdilution broth method according 
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to the guidelines provided by The Clinical and Laboratory Standards Institute (CLSI). 
Additionally, the Etest Antibiotic Susceptibility Assay was performed as confirmation to 
the MIC assay. Details regarding the results of these tests are discussed in the ‘results and 
discussion’ section. Briefly, the mutation of the msa gene rendered the strain 
hypersusceptible to oxacillin in comparison to the wild type strain COL. This 
phenomenon was evident in the E-test as well. In order to understand the regulatory 
mechanisms involved in msa mediated antibiotic resistance, additional genetic and 
phenotypic experiments were conducted to elucidate possible pathways by which the msa 
gene regulated antibiotic resistance.     
Materials and Methods 
Bacteria and Growth Conditions 
The homogeneously Methicillin-Resistant S. aureus (MRSA) strain COL was 
used in this study. Strains were grown on tryptic soy agar (TSA) or in tryptic soy broth 
(TSB) at 37°C under constant aeration, supplemented with antibiotics where appropriate. 
Erythromycin 10 g/ml and chloramphenicol 10 g/ml were used to select for the msa 
mutant and complemented msa mutant, respectively. Meuller-Hinton broth (MHB) or 
agar (MHA) with 2% NaCl (cation-adjusted for oxacillin) was used in determining the 
Minimum Inhibitory Concentration (MIC). 
Phage Farming and Transduction 
Generalized transduction with phage 11 was utilized to generate an msa mutant 
and a complemented msa mutant in the COL strain.  A phage lysate was prepared by 
overlaying TSA plates with TOP Agar (3 grams of TSB, 0.7 grams of Bacto™ Agar, 100 
ml dH20, autoclaved and cooled to 50°C before use) containing 100 l of cells from a 
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moderately-thick (1/4th of a plate) suspension of the donor strain, 100 l of phage (10-fold 
serial dilutions, from -1 to -5) and 40 l of 500mM CaCl2.  The plates were incubated 
overnight at room temperature. The next day, the plate with the least amount of phage 
and the most clearing was harvested and the suspension was filter-sterilized using a 
0.2 m filter. A 100 l aliquot was plated on a TSA plate to test for sterility of the lysate. 
To perform the transduction, 500 l of recipient-strain cells (from a very heavy 
suspension; full plate of cells into 2ml of medium) were added to 500 l of the prepared 
phage lysate in 1ml of TSB containing 20 l of 500 mM CaCl2. The mixture was 
incubated at 37°C with vigorous shaking for exactly 20 minutes. At the end of 20 
minutes, 1ml of ice-cold 0.02M sodium citrate was added and the tube was placed on ice. 
Cell pellets were collected by centrifugation and the pellets were resuspended in 500 l 
of 0.02M sodium citrate before being plated onto TSA plates containing selective 
medium and 500 g/ml of sodium citrate. Colonies appearing on these plates were re-
streaked and screened using PCR and/or restriction digestion.   
Minimum Biofilm Eradication Concentration (MBEC) assay 
The MBECTM Physiology and Genetics Assay (Innovotech, Inc., Canada) was 
used to determine the effect of oxacillin on msa mutant biofilm versus the wild type 
biofilm. Procedures were carried out as per instructions of the manufacturer. Briefly, the 
MBEC device uses a standard 96-well configuration with two parts: 96 identical 
polystyrene pegs protruding from a lid and a 96-well microtitre plate base. Pegs were 
immersed in growth medium containing the test strains (matching 1.0 McFarland 
standard) and were incubated overnight at 37°C. Biofilm formed on these pegs were 
rinsed with PBS and transferred to another 96-well plate containing varying 
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concentrations of antibiotics. After overnight incubation, the cells in the biofilm were 
disrupted and collected into fresh growth medium using a water bath sonicator. Collected 
cells were allowed to grow for another 24 hrs before assessing the MBEC (the lowest 
concentration of antibiotics that was able to eradicate cells in a biofilm).  
Culture Conditions for Oxacillin-Induced Analysis 
Tryptic Soy Broth (TSB) was inoculated with the respective overnight cultures.  
Cells were grown until OD560nm of 0.9 with shaking at 150rpm and at 37°C.  At this point, 
cells were split into two flasks.  One volume was treated with oxacillin (5X lower than 
MIC) and the other was left untreated (control).  Both cultures were incubated again with 
shaking at 150rpm and at 37°C.  Samples were collected from control and oxacillin-
treated cultures at 1 hour and 6 hours post addition of oxacillin.  These samples were 
processed additionally for TEM and Real-time quantitative PCR analysis.  
Transmission Electron Microscopy 
Cell pellets were collected as mentioned above and resuspended in a 4% 
gultaraldehyde solution. Then the cells were treated with osmium tetroxide, dehydrated 
through a graded series of alcohols and propylene oxide, and then infiltrated with Epon 
plastic.  The Epon blocks were cured overnight in a 60°C oven and 70 nm sections were 
cut using a Leica ultramicrotome. Sections were stained with uranyl acetate and lead 
citrate and viewed on a Leo 912 transmission electron microscope. 
Atomic Force Microscopy 
AFM was done as previously described by Dubrovin et al., (42). Briefly, cell 
pellets were collected as mentioned above and were washed 3x in ice-cold sterile distilled 
water for 10 minutes at 10,000 rpm and 4 C. Then the cells were resuspended in 1/10th 
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the volume using ice-cold sterile distilled water. Immediately, 5μl of resuspended cells 
were deposited on freshly cleaved mica as a substrate. The sample was allowed to air dry 
for 5-10 minutes for adsorption and then rinsed with sterile distilled water three times and 
dried in nitrogen flow. 
All AFM measurements were recorded in air using a Nanoscope III microscope 
(Digital Instruments, Santa Barbara, CA) equipped with 150 μm scanner in tapping 
mode. The commercial noncontact silicon cantilevers had typical stiffness of 20-80 N/m; 
their resonance frequency was in the range of 321-373 kHz. The scan frequency was 
about 0.25 Hz. All AFM images were recorded simultaneously in two channels: height 
and phase. Image processing was performed using Gwyddion software (version 2.20, 
http://gwyddion.net/). For accurate numerical measurements, height images were used. 
RNA Isolation and cDNA Synthesis 
Total RNA was isolated from cell pellets (collected as mentioned above) using the 
RNeasy Mini column (Qiagen). RNA was treated twice with DNase and analyzed for 
quality and concentration using Agilent’s Total RNA Nano 6000 protocol. Appropriate 
amounts of total RNA were converted to cDNA using BioRad’s iScript cDNA synthesis 
kit. cDNA was stored at -20°C until use. Differential gene expression data was derived 
from at least two independent biological replicate samples. 
Real-time Quantitative PCR (RT-qPCR) 
Gene expression analysis by RT-qPCR was performed with all reactions done in 
triplicate using the iQ SYBR Green Supermix and the BioRad iCycler iQ Real-time PCR 
detection system.  The constitutively expressed gyrase gene (gyr) was used as an 
endogenous control. Primer specificity and efficiency was measured as described 
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previously (130).  Expression analysis for each gene was based on at least two 
independent experiments.  Two-fold or higher changes in expression were considered 
significant. 
Western-blot Analysis 
Cells were collected as described above and were frozen at -80 C. Cell pellets 
were resuspended in 300 μl of sterile 1x PBS. A sonicator was used to disrupt the cell 
membrane and lyse the cells. Cells were sonicated (Misonix XL 2000, Newton, CT; set at 
14 volts) for 15 seconds at a time to avoid overheating and kept in ice for cooling. After 
10 cycles, 10 μl of the cell mixture was added to 20 μl of 3x sample buffere and boiled 
for 5 mins at 95 C. Protein concentration was measured using Bradford assay. The total 
protein mixture from each of the strains were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred onto a PVDF membrane for western 
blot analysis as described previously by Zhang et al. (161). The primary polyclonal 
antibody, anti-pbp2a, was custom ordered from ProSci, Inc., (Poway, CA) and was used 
as per supplier’s instructions. Blotting and analysis was done as previously described by 
Blevins et al. (15). 
Triton X-100 Induced Autolysis 
Autolysis assay was conducted using Triton X-100 as described by Manna et al. 
(97). Overnight bacterial cultures were diluted to an OD650 of 0.5 in TSB-N (TSB + 1M 
NaCl). Cells were grown until OD650 reached 0.7-1.2.  Cells were washed twice with ice-
cold dH2O and harvested by centrifugation at 10,000 RPM for 5 min. Washed cells were 
resuspended in 0.05M Tris-HCl, pH 7.5 buffer (control) or 0.05M Tris-HCl, pH 7.5 
buffer containing 0.05% (wt/vol) Triton X-100 (stimulated). Triton X-100 stimulated 
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lysis was recorded by incubating cells at 30°C with shaking and measuring optical 
density at OD650 every 30 min. 
Heat Shock Assay 
Fresh medium was inoculated with overnight cultures of respective strains. The 
cells were allowed to grow until they reached exponential growth (OD560 0.7). Cells were 
split into two and were allowed to grow in 42 C and 37 C as test and control samples, 
respectively. The growth rate was monitored every hour. Results from the 42 C 
incubation are reported.  
Microarray Analysis 
Microarray experiments were done using S. aureus COL genome microarrays 
(version 6.0), provided by Pathogen Functional Genomics Resource Center (PFGRC). 
The entire experiment was done according to the TIGR protocols found on their website 
at: http://pfgrc.tigr.org/protocols/protocols.shtml 
RNA Labeling and Hybridization 
RNA labeling and hybridization was done according to the TIGR protocol 
(Standard operating procedure no. M0007:http://pfgrc.tigr.org/protocols/protocols.shtml). 
Briefly, random hexamers (Invitrogen) as primers were annealed to 2.5 μg of the total 
RNA (70oC for 10 min, followed by snap-freezing in ice for 1 min), along with 
RNaseOUT recombinant ribonuclease inhibitor (Invitrogen). The primers were then 
extended using SuperScript II reverse transcriptase (Invitrogen) with 0.1 M DTT and 12.5 
M of aa-dNTP/aa-dUTP mix (Ambion, Austin, TX) at 42oC overnight.  Residual RNA 
was removed by alkaline treatment with 1 M NaOH followed by neutralization with 1 M 
Tris (pH 7.4). The resulting cDNA was purified using Qiagen MinElute PCR purification 
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kit (Qiagen) and labeled with Cy3 and Cy5 mono-Reactive dyes (Amersham Biosciences, 
Pittsburg, PA) as per manufacturer’s instruction.  
Labeled cDNA was purified using MinElute PCR purification kit and hybridized 
with S. aureus COL genome microarrays (version 6.0), provided by Pathogen Functional 
Genomics Resource Center (PFGRC), as per the TIGR protocol (Standard operating 
procedure no. M0008: http://pfgrc.tigr.org/protocols/protocols.shtml). Briefly, the slides 
were treated with a preheated pre-hybridization buffer (5X SSC [Ambion], 0.1% SDS 
and 1% BSA [Sigma, St. Louis, MO]) at 42oC for 1 hr. Slides were then washed with 
distilled water followed by washing with isopropanol and dried by centrifuging. The 
dried Cy3 and Cy5 labeled cDNA was resuspended using hybridization buffer (50% 
formamide, 5X SSC, 0.1% SDS and 300 μg sheared salmon sperm DNA [Ambion]) and 
denatured at 95oC. The sample was then applied to the pre-hybridized slides under the 
LifterSlip (Fisher, Pittsburg, PA). The slides were incubated at 42oC overnight. Next day, 
the hybridized slides were serially washed with low, medium and high stringency wash 
buffers, dried by centrifuging and scanned using Axon 4200A scanner (Molecular 
Devices, Sunnyvale, CA). Microarray scans were saved as TIFF images. 
Microarray Data Analysis 
GenePix Pro 6 (Molecular Devices) was used to extract the spot intensity values 
and generate GPR files from the microarray image files. Further data analysis was done 
using the Acuity 4.0 software (Molecular Devices). Four hybridizations were performed 
for this experiment, including a biological replicate and a dye-swap experiment for each 
replicate to account for dye-bias. Spots flagged as empty or bad were excluded and the 
raw data from each slide was normalized using LOWESS method, with background 
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correction. The data from the replicates were combined (using the median value) and a 
one sample t-test was performed. The volcano plot was used with a fold change cut-off of 
>= 3 and a p-value of <0.05 to filter the genes that are differentially expressed. 
ORF IDs in the list of differentially expressed genes were mapped to S. aureus 
N315 IDs using TIGR-PFGRC annotation file: http://pfgrc.tigr.org/annotationPages.shtm 
Results and Discussion 
msa is Involved in Antibiotic Resistance 
Since methicillin is no longer used in the clinical settings, oxacillin was used in 
this study. MIC values of the msa mutant showed that the disruption in the msa gene 
rendered the homogenously methicillin-resistant strain COL hypersusceptible to 
oxacillin. Minimum inhibitory concentration of oxacillin on average went from 1000 
μg/mL down to ~4 μg/mL (Table 4.2). The complemented msa mutant was able to 
restore resistance back to wild type levels.  Etest results also confirmed the drastic 
differences in MIC values (Figure 4.1). Wild type strain COL’s oxacillin MIC was very 
high at >256 g/ml. The Etest strip had an upper limit of 256 g/ml, therefore it does not 
reflect the higher wild type MIC values seen with the micro-broth dilution method. 
Although a lawn-like growth did not occur in the wild type Etest, according to 
manufacturer’s instructions, the presence of colonies is indicative of resistance (Figure 
4.1). The msa mutant, on the other hand, had a clear zone of inhibition starting at 1.5 


















msa complement 1000 
RN6390 0.9765 
 
Note. The msa mutant was hypersusceptible to oxacillin in comparison to the wild type strain COL and the complemented msa mutant. 
The methicillin-susceptible S. aureus (MSSA) strain RN6390 was used as a control. The assay was performed three independent times 
and an average value is reported here.  
 
 
Figure 4.1. Oxacillin E-test using the COL wild type and msa mutant strains. 







Antibiotic Susceptibility Prevails under Biofilm Conditions 
Since antibiotic resistance is amplified in a biofilm state of growth (67), a 
minimum biofilm eradication concentration (MBEC) assay was performed to assess and 
compare the oxacillin concentration required to inhibit growth of cells within a biofilm in 
the msa mutant versus the wild type strain COL. Remarkably, the msa mutant was again 
hypersusceptible to oxacillin, albeit at a relatively higher concentration in comparison to 
planktonic growth conditions (Table 4.3). This effect is probably due to the protective 
environment afforded by the biofilm. In the msa mutant, however, the biofilm is defective 
(see Chapter III) and does not mature into a robust, protective environment. So, any 
protection afforded by the biofilm is at best very minimal. 
Table 4.3 
 
msa Mutant Biofilm is Susceptible to Antibiotics as Evidenced by the Minimal Biofilm 
Eradication Concentration (MBEC) Assay 
  Strain MBEC (μg/ml) 
COL, wild type 1500 
msa mutant 187.5 
msa complement 1500 
 
Note. Biofilm is grown on uniform individual pegs and then is exposed to varying concentrations of antibiotics. Cells that are able to 
resist the antibiotics are allowed to recover in fresh medium and the lowest concentration of antibiotics that was able to eradicate cells 
in a biofilm is reported as the MBEC. Results are an average of two independent runs. 
 
Msa Aids in Maintaining Cell Integrity in the Presence of Antibiotics 
Several studies have shown that the morphology of the cell wall of strains with 
increased susceptibility to -lactams often show some degree of damage as a result of 
exposure to these antibiotics. In order to visualize the damaged caused as a result of a 
non-functional msa gene, transmission electron microscopy (TEM) and atomic force 
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microscopy (AFM) studies were conducted. TEM and AFM were chosen to discern 
differences in cell wall stability and cell surface organization, respectively. Cells were 
treated and harvested as in other procedures, before being prepared for each of these 
microscopy procedures. TEM images (Figure 4.2) of the msa mutant at 4000x 
magnification showed that there was increased lysis of the msa mutant cells upon 
addition of oxacillin. It is interesting to note the degree of damage incurred by the cells 
when the amount of oxacillin added to the msa mutant was just 0.625 μg/ml, whereas the 
amount added to the wild type strain and the complemented strain was 320 μg/ml (1/5th 
of their respective MICs). Upon closer investigation (Figure 4.3) at a higher 
magnification of 20000x, the effects of msa mutation on the cell wall integrity were even 
more evident. Majority of the wild type and complemented msa mutant cells were intact 
in comparison to the msa mutant. It is possible that this loss in cell wall integrity could be 
due to the lack of msa—a putative membrane protein, which may be involved in sensing 
the external environment and relaying the appropriate signals to prepare the cell wall 
machinery for an onslaught of antibiotics. Genetic and functional studies were conducted 
to further understand the role of msa in this process (see below). The complemented msa 
mutant on average exhibited two different cell sizes when exposed to oxacillin. This 
could be possibly be a result of overexpression of msa in some cells versus the others, 
however, further experimentation using a controlled msa expression mechanism will be 





Figure 4.2. TEM images of wild type strain COL, msa mutant, and complemented msa 
mutant at 4000x magnification. Cells in the bottom panel were treated with oxacillin at 
1/5th the amount of respective MIC values and the cells in the upper panel served as 





Figure 4.3. TEM images of wild type strain COL, msa mutant, and complemented msa 
mutant at 20,000x magnification. Cells in the bottom panel were treated with oxacillin at 
1/5th the amount of respective MIC values and the cells in the upper panel served as 
untreated controls. The msa mutant showed increased lysis upon addition of oxacillin, 
whereas majority of the wild type and complemented msa mutant cells were able to 
maintain cell wall integrity.    
 
 AFM images were obtained as previously described by Dubrovin et al. (42). 
Measurements were recorded in air using a Nanoscope III microscope (Digital 
Instruments, Santa Barbara, CA) equipped with 150 μm scanner in tapping mode. The 
commercial noncontact silicon cantilevers had typical stiffness of 20-80 N/m; their 
resonance frequency was in the range of 321-373 kHz. The scan frequency was about 
0.25 Hz. All AFM images were recorded simultaneously in two channels: height and 
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phase. Image processing was performed using Gwyddion software (version 2.20, 
http://gwyddion.net/). For accurate numerical measurements, height images were used. 
Preliminary AFM images of the msa mutant’s cell surface (Figure 4.4.) showed that the 
cell wall could possibly be damaged as a result of msa mutation (possible regions of 
perturbations in the cell wall are indicated with blue arrows). In comparison, the wild 
type strain COL (Figure 4.5.) did not show any distinct damages in the cell wall surface. 
In order to conclusively demonstrate that mutation of msa causes phenotypic changes in 
the cell wall of S. aureus, additional AFM imaging using control cells under normal and 












        
Figure 4.4. AFM images of the msa mutant cells exposed to oxacillin. Blue arrows 





             Figure 4.5. AFM images of the wild type COL cells exposed to oxacillin.   
 
Msa Regulates mecA Expression 
MRSA strains express an additional penicillin-binding protein (Pbp) called Pbp2a 
that is encoded by the mecA gene carried on the SCCmec mobile element. Real-time 
quantitative PCR was performed to compare mecA gene expression in oxacillin-induced 
and control samples of wild type strain COL, the msa mutant and the complemented msa 
mutant. Along with the mecA gene, the SCCmec element usually carries the mecA 
regulatory genes such as mecI and mecR1. In the MRSA strain COL, however, the mecI 
gene is non-functional. Therefore, expression of the mecR1 gene was analyzed. Relative 
gene expression was calculated using the delta-delta Ct method (Table 4.4). In 
comparison to the control samples, oxacillin-induced samples from the msa mutant 
showed a drastic reduction (undetectable levels) in mecA gene expression. 
Complemented msa mutant restored mecA gene expression to near wild type levels. Next, 
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expression levels of the Pbp2a protein were analyzed using western blot analysis. In the 
msa mutant Pbp2a levels were lower than the wild type strain COL and complemented 
msa mutant levels (Figure 4.6). These results were in agreement with the RT-qPCR 
results, albeit not to a similar extent. Unless protein-protein interaction studies are done, 
it is not possible to know whether Msa directly or indirectly (through another protein) 
interacts with the Pbp2a.  
Table 4.4 
 
Relative Gene Expression of mecA and mecR1 
 
Planktonic Cells Gene 
0.3 1.5 4.0 
mecA <0.0001 <0.0001 <0.0001 
mecR1 <0.0001 <0.0001 <0.0001 
 
Note. Relative gene expression of the mecA and mecR1 gene in the msa mutant compared to the COL wild type strain. Similar 




Figure 4.6. Western blot analysis showing the levels of Pbp2a in the wild type strain 
COL, msa mutant and the complemented msa mutant.  
 
Msa Regulates Expression of Cell Wall and Cell Wall Precursors 
Collectively, these results indicated that the msa gene plays a major role in -
lactam antibiotic resistance in Staphylococcus aureus. Based on these results, further 
experiments were necessary to narrow down the role of msa in the antibiotic resistance 
mechanisms. To that effect, first, a list of several chromosomally encoded genetic factors 
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involved in antibiotic resistance was generated from previous studies conducted by other 
investigators (see Table 4.1). In order to achieve a manageable number of genes for initial 
RT-qPCR analysis the list was further reduced to genes that showed a 3-fold or higher 
difference in a microarray analysis of the msa mutant versus the wild type COL. This 
microarray analysis, however, was done using samples that were collected without any 
oxacillin treatment, thus it served more as a guideline rather than a definitive cut off 
measure. Cells were collected from oxacillin treated and untreated control samples. Total 
RNA was isolated and was used to generate the cDNA that was used as the template for 
the RT-qPCR analysis. Relative gene expression of target genes was calculated using the 
delta-delta Ct method and the results are summarized in Table 4.5 (untreated control 
samples) and Table 4.6 (oxacillin-induced samples). 
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Table 4.5  
 
Relative Gene Expression of msa Mutant Compared to Wild Type COL in Untreated 








    
femA SA1206 Nonribosomal peptidyltransferase aminoacyltransferase -7.143* 








SA1965 Phosphoglucoasmine mutase -1.481 
femX, 
fmhB 




Cell envelope protein with LPXTG-motif, function 




SA1193 Lysylphosphatidylglycerol synthetase -1.724 
llm, tagO SA0702 




hmrA SA1935 Similar to amidase -1.220 
sigB SA1869 Alternative, stress inducible sigma factor B -1.675 
aux4 SA1557 Catabolite Control 1.480 
aux7 SA1572 Amino acid metabolism 1.505 
aux9 SA1137 Involved in DNA repair -1.005 
aux10 SA1489 Hypothetical Protein -1.026 
aux14 SA0722 Unknown Protein -9.091* 








UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 -1.242 
murC SA1561 UDP-N-acetylmuramate--alanine ligase 1.445 






mraY SA1025 Phospho-N-acetylmuramoyl-pentapeptide-transferase -2.381* 
pbpA SA1024 Penicillin-binding protein 1 -1.515 
pbpB SA1283 Penicillin-binding protein 2 -1.198 
pbpC SA1381 Penicillin-binding protein 3 -1.923 
pbpD SA0598 Penicillin-binding protein 4 1.870 





Relative Gene Expression of msa Mutant Compared to Wild Type COL in Oxacillin-








    
femA SA1206 Nonribosomal peptidyltransferase aminoacyltransferase -1.626 








SA1965 Phosphoglucoasmine mutase -3.846* 
femX, 
fmhB 




Cell envelope protein with LPXTG-motif, function 




SA1193 Lysylphosphatidylglycerol synthetase 1.215 
llm, tagO SA0702 
Lipophilic protein, undecaprenyl-phosphate- -N- 
acetylglucoasminyl -1-phosphate transferase 
-1.460 
hmrA SA1935 Similar to amidase 1.320 
sigB SA1869 Alternative, stress inducible sigma factor B -2.899* 
aux4 SA1557 Catabolite Control 1.290 
aux7 SA1572 Amino acid metabolism 2.955* 
aux9 SA1137 Involved in DNA repair 1.809 
aux10 SA1489 Hypothetical Protein 1.400 
aux14 SA0722 Unknown Protein -5.714* 








UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 -22.222* 
murC SA1561 UDP-N-acetylmuramate--alanine ligase 1.690 






mraY SA1025 Phospho-N-acetylmuramoyl-pentapeptide-transferase -1.053 
pbpA SA1024 Penicillin-binding protein 1 1.449 
pbpB SA1283 Penicillin-binding protein 2 -1.342 
pbpC SA1381 Penicillin-binding protein 3 1.465 
pbpD SA0598 Penicillin-binding protein 4 2.430* 




 Most notably among the aux genes, the expression of aux14 was down by 5.7- 
and 9-fold in the msa mutant under oxacillin-treated and untreated conditions, 
respectively (Figures 4.5. and 4.6). In a 1994 paper by de Lencastre and Tomasz (39), an 
aux14 mutant (designated as strain RUSA262) was described as exhibiting distinct 
abnormalities in the peptidoglycan. The MIC of methicillin for the aux14 mutant was 
reported as 12 g/ml in comparison to the 1600 g/ml of the wild type strain COL. This 
effect is similar to the hypersusceptibility seen in the COL msa mutant. The authors of 
this study did not provide additional mechanistic details regarding aux14 susceptibility. 
Till date, there have been no follow-up studies on aux14. Given the possibility that the 
msa gene encodes for a membrane protein, it is speculated that the msa gene might be 
involved in directly regulating the expression of aux14 in order to maintain cell wall 
integrity. According to analysis done using SAMMD (107), microarray analysis of the 
sigB regulon (13), revealed that aux14 is upregulated by the sigB gene. The sigB gene, a 
stress response regulator, was expressed in the msa mutant at wild type levels in the 
absence of oxacillin (Figure 4.7) However, in the presence of oxacillin the sigB 
expression was down by 3-fold in the msa mutant in comparison to the wild type strain 
(Figure 4.8). Therefore, the reduced expression of aux14 could be partially attributed to 






   
Figure 4.7. Relative gene expression analysis of the aux genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 






Figure 4.8. Relative gene expression analysis of the aux genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 




 In order to understand if hypersusceptibility of the msa mutant to oxacillin was 
due to reduced expression of the sigB gene, i.e., an inability to cope with the stress 
presented by the antibiotic, a heat shock assay was performed because it is known to 
induce sigB activity. Cells were grown to the exponential phase (OD560 0.7) at 37 C and 
then transferred to 45 C. Differences in growth between the wild type, msa mutant and 
complemented msa mutant were monitored over a 6-hour period (Figure 4.9). The msa 
mutant in comparison to the wild type and complemented msa mutant did not show any 
significant changes in growth. It appears that a decrease in SigB is not related to the 
antibiotic susceptibility seen with the msa mutant since the mutant is able to grow similar 
to wild type levels. Additional studies have to be conducted to establish a more concrete 
relationship between these genes since SigB is involved in other stress-related response 
mechanisms. 
 
Figure 4.9. Heat shock assay performed on wild type COL, msa mutant and 
complemented msa mutant.  
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  The fem genes (factors essential for the expression of methicillin resistance) are 
important components of the cell wall machinery. Mutation of msa caused a 7.1- and 2.6-
fold decrease in femA and femB expression, respectively (Figure 4.11). The femA gene 
encodes for a 48 kDa protein that belongs to the FemABX family of nonribosomal 
peptidyl transfereases. These three transferases are responsible for synthesizing the 
pentaglycine interpeptide bridge for the peptidoglycan layer. FemA, specifically, adds the 
2nd and 3rd glycine to the pentapeptide interpeptide. An inactivated femAB, leads to the 
reduction of the interpeptide to a monoglycine, leading to a poorly cross-linked 
peptidoglycan.  In MRSA strains, methicillin-resistance is completely abolished upon 
inactivation of femA (70). The protein product of the femB gene is responsible for adding 
the 4th and 5th glycine to the pentapeptide interpeptide bridge.  Henze et al., showed that a 
transposon mutant of the femB gene exhibited increased levels of beta-lactam 
susceptibility in amounts comparable to a femA mutant (64).  
 femX, also known as fmhB, is an essential gene that adds the first glycine to the 
pentapeptide interpeptide (148). Mutation of femX produces a null mutant. It is possible 
that the drastically reduced MIC values seen in the msa mutant is due to the ill-formed 
peptidoglycan layer. Interestingly, the femX, and not femA and femB, was expressed 
lower in the msa mutant exposed to oxacillin (Figure 4.12). These three gene products are 
critical in the proper cross-linking of the peptidoglycan layer and have been considered as 
attractive antistaphylococcal targets (83). Lysostaphin is a metalloendopeptidase 
produced by Staphylococcus simulans that specifically cleaves the pentaglycline cross-
bridges that are formed by femX, femA and femB.  A lysostaphin susceptibility assay was 
performed to see the effect of reduced expression of femXAB. As expected, the msa 
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mutant had a slower rate of lysis in comparison to the wild type and complemented msa 
mutatnt strain (Figure 4.10). It is possible that the lack of substrate for lysostaphin to act 
upon was in fact the reason for reduced lysis. Indeed, Maidhof et al. have shown that the 
femA mutant has reduced lysostaphin-induced lytic activity due to the lack of glycines in 
the peptidoglycan (95). It is unclear at this stage why the complemented msa mutant 
showed similar lysostaphin susceptibility profile as the msa mutant. Given the effect Msa 
has on all three transferases, a therapeutic agent designed against Msa could serve to 
disrupt the functions of all three transferases and thereby rendering the peptidoglycan 
layer unstable. 
 
Figure 4.10. Lysostaphin susceptibility assay. The msa mutant is less susceptible to 
lysostaphin in comparison to the wild type strain COL. Lysostaphin’s target, the 
pentaglycine cross-bridge is possibly less in the msa mutant thereby denying lysostaphin 
a substrate to act upon. The results are an average of two independent runs containing 
two technical replicates each.  
 
 femD, also known as glmM encodes for a phosphoglucosamine mutase that 
converts glucosamine 6-phosphate to glucosamine 1-phosphate. This is the initial step in 
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the production of UDP-N-acetylglucosamine, the nucleotide sugar that is involved in 
peptidoglycan synthesis. GlmM mutants exhibited a 5% decrease in peptidoglycan cross-
linking, however, did not adversely affect the fitness of S. aureus. This indicates that 
there may be alternative pathways to synthesize glucosamine 1-phosphate (53). 
Reduction in the amount of GlmM alone may not have been sufficient for the increased 
susceptibility seen in the msa mutant but the combinatorial effect of reduction in the fem 
and glmM genes may explain the high degree of degradation seen in the msa mutant 
cells’ TEM images. Disrupting Msa’s function not only affects factors involved in 
building the peptidoglycan layer, but also the factors that are involved in assembling and 
processing the precursor structures involved in the peptidoglycan formation. 
 mur genes (murA, murB, murC, murD, murE, murF, and murG) comprise of 
ligases, reductases, and transferases that are involved in assembling the building blocks 
of the peptidoglycan on the cytoplasmic side of the process (43, 116) (Figure 4.13). 
Although the mechanistic details of the mur genes’ regulation is yet to be fully 
deciphered, a lot has been studied and understood about their sequential assembly. When 
the process begins, MurA is responsible for the transfer of an enolpyruvate residue from 
phosphoenolpyruvate (PEP) to the 3rd position of UDP N-acetylglucosamine. 
Consequently, the enolpyruvate moiety is reduced to D-lactate, yielding UDPN-
acetylmuramate. Next, the stem pentapeptide side-chain (L-alanine, D-glutamine, L-
lysine, D-alanine, D-alanine) is added on to the recently reduced D-lactyl group in a 
sequential manner by MurC, MurD, MurE and MurF. All these processes are ATP-






Figure 4.11. Relative gene expression analysis of the fem genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 





Figure 4.12. Relative gene expression analysis of the fem genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 





Figure 4.13. Protein structure of MurA, B, C, D, E and F using the oval ribbon model. 
Image source: (43) 
 
 In a subset of Gram-positive organisms, murA contains a paralogue (79). In this 
case, the two genes are referred to as murAA and murAB. Protein sequence analysis using 
MATCHER (Waterman-Eggert local alignment tool) of MRSA strain COL revealed that 
there is a 47% identity and 63.7% similarity between the two murA paralogues. In the 
msa mutant, the expression of murAA remained unchanged in comparison to the wild 
type (Figures 4.12 and 4.13). The expression of murAB, however, was more than 22-fold 
lower in the msa mutant in samples treated with oxacillin (Figure 4.15). In contrast, 
murAB levels remained similar to wild type levels in untreated samples (Figure 4.14). 
Kock et al. (2004) have shown in B. subtilis that murAB cannot compensate for loss of 
murAA function. Inversely, it is possible that, although transcripts of murAA are being 
produced in the msa mutant in the conditions tested, it may not be fully sufficient to take 
over the role of murAB. It is speculated that msa regulates the expression of murAB, 
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which, under certain conditions could be partially responsible for the first step in 
cytoplasmic-side of peptidoglycan biosynthesis.  Further studies have to be conducted in 
order to fully elucidate the significance of the loss of murAB transcript.  
Murein hydrolases play important roles in a variety of cellular processes, such as 
cell wall growth, cell wall turnover, cell separation, the recycling of muropeptides, lysis 
induced by cell wall synthesis inhibitors, the establishment of competence for genetic 
transformation, flagellum formation, sporulation, and in bacterial pathogenicity processes 
(50, 68, 138). Those murein hydrolases that lead to the destruction of the cell wall and 
subsequent cell lysis are called autolysins. Because of the capacity to destroy the cell 
wall, the expression and activity of murein hydrolases must be tightly controlled. If 
uncontrolled, these hydrolases can compromise cell wall integrity, lead to the destruction 
of the cell wall, and cell lysis ensues. This reaction is similar to what happens to a typical 
methicillin-susceptible S. aureus in the presence of a -lactam (144). Gustafson and 
Wilkinson showed that a homogenously resistant strain such as COL has a lower 
autolytic activity than susceptible strains (58). It is not inconceivable that the cell 
downregulates autolytic activity while trying to maintain a proper cell wall that is being 
disrupted by the antibiotics. If mutation of msa affects cell wall or cell-wall precursor 
proteins, it is possible that the autolytic pathway involved in cell wall turnover and 
recycling of muropeptides is affected as well. Triton X-100 induced autolytic assay (97) 
was performed to compare lytic activity between the wildtype and the msa mutant. The 
msa mutant in the presence of Triton X-100 had increased lysis in comparison to the wild 
type strain COL (Figure 4.16). Previously it was shown that the major autolysin, atl, is 





Figure 4.14. Relative gene expression analysis of the mur genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 






Figure 4.15. Relative gene expression analysis of the mur genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 




increased lysis in the mutant is a result of another unknown autolytic mechanism that was 
repressed by the msa gene. However, studies have shown that gene expression is different 
under biofilm and planktonic growth conditions (11). Thus, it is also possible that atl is 
differentially regulated under the conditions used in this study and is possibly the reason 
for the increased autolytic activity seen in the msa mutant.   
 The mraY gene encodes for a Phospho-N-acetylmuramoyl-pentapeptide-
transferase that is responsible for completing the first membrane step of peptidoglycan 
biosynthesis (17). MraY is an essential integral membrane protein that transfers the 
Phospho-N-acetylmuramoyl-pentapeptide onto the undecaprenyl phosphate carrier lipid, 
Lipid II. Due to the critical nature of this protein, it has been considered as a prime target 
for therapeutic agents. In the msa mutant, the expression mraY was down by 2.3-fold 
(Figure 4.14), however, in the presence of oxacillin, the expression of mraY was similar 
to wild type levels (Figure 4.15) It is possible that Msa, a putative membrane protein, 
could be involved in sending signals into the cell for increased or decreased transcription 
of mraY depending on the environmental conditions. Or the effect seen with mraY could 
be an indirect result of the perturbation in Msa. 
Penicillin-binding proteins (Pbp1, 2, 3 and 4) are involved in the construction and 
cross-linking of the peptidoglycan layer. Pbp1 is an essential PBP that is involved in cell 
division process (117, 120, 152). Pbp2  is a bifunctional PBP that conducts both 
transpeptidase and -lactam-insensitive transglycosylase activities (91, 120).  Penicillin-
binding protein 3 and Pbp4 are not essential for growth (76, 120, 158). Inactivation of 
Pbp3 does not cause any changes in the cell wall composition, nor does it affect the 
growth rate. It was concluded that Pbp1 might be taking over the role of Pbp3, thus 
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accounting for the lack of phenotypic alterations (49, 118, 120). RT-qPCR analysis 
revealed that in the msa mutant samples collected from non-oxacillin-induced growth 
conditions, the pbp genes were all expressed in amounts similar to that of the wild type 
strain (Figure 4.17). Under oxacillin-induced conditions, however, all but pbp4 were 
expressed in amounts similar to wild type (Figure 4.18). pbp4 was expressed more than 
2-fold in the msa mutant in comparison to the wild type. Recent studies have shown that 
a functioning Pbp4 is essential for the full expression Pbp2 when community-acquired 
MRSA (CA-MRSA) were challenged with oxacillin (103). It is possible that this Pbp4 
requirement is not specific to CA-MRSA strains, since MRSA strain COL used in this 
study is a HA-MRSA strain. Apart from the explainable increase seen with the expression 
of pbp4, the mutation of msa does not appear to play a role in the expression of genes 
encoding for penicillin-binding proteins. 
 All genes (tested under both oxacillin-induced and uninduced conditions) that had 
a relative fold change of 2-fold or higher have been summarized in a graphical format in 
Figure 4.19. From this data, it is evident that the mutation of msa possibly affects a wide 
range of genes involved in cell wall synthesis, cell wall precursor synthesis and stress 





Figure 4.16. Triton X-100 induced lytic assay. The msa mutant (closed triangle) in the 
presence of Triton X-100 had increased lysis in comparison to the wild type strain COL 
(closed diamonds). The complemented msa mutant (closed circle) had an intermediate 
rate of lysis. Open symbols represent the respective strains used as a control without 
Triton X-100 treatment. The values presented here are an average of two independent 










Figure 4.17. Relative gene expression analysis of the pbp genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 






Figure 4.18. Relative gene expression analysis of the pbp genes in the msa mutant vs. wild type strain COL. 
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated 






Figure 4.19. Relative gene expression analysis of the genes showing significant differences in the msa mutant vs. 
wild type strain COL. Fold change values are an average of two independent runs. Two-fold decrease in fold 
change is indicated with a red dashed line and a two-fold increase in fold change is indicated with a green dashed 




 Msa was predicted to be a membrane protein with three transmembrane domains 
that contained phosphorylation and binding sites (Figure 2.2). This suggested that Msa 
might interact with the external environment (108) and act as a sensor for an external 
signal that modulates sarA expression and thereby regulates the expression of  several S. 
aureus virulence factor (130).  Disrupting the msa gene caused a drastic decrease in 
antibiotic resistance levels of a homogenously resistant MRSA strain. Phenotypic and 
RT-qPCR results from this study have shown that msa regulates the expression of several 
chromosomally encoded genes that are involved in methicillin resistance. Also, it appears 
that the msa mutant is unable to form a proper cell wall and is further challenged upon 
addition of oxacillin. Thus, msa is a major regulator of antibiotic resistance in 
methicillin-resistant Staphylococcus aureus (MRSA). The mecA gene, whose protein 
product, Pbp2a, is primarily responsible for the MRSA phenotype, appears to also be 
regulated by Msa. However, the fact that msa regulates the expression of several 
chromosomally encoded cell wall synthesis and cell wall synthesis precursor genes 
makes it a promising target for future antibiotic therapies. Msa positively regulates the 
expression of sarA (130), a global regulator that controls the expression of over 100 
genes. It is possible that other antibiotic-resistance-related genes are also regulated by 
msa, either via sarA or independent of sarA. 
In order to further understand the global role of Msa in S. aureus, a DNA 
microarray analysis was conducted using samples exposed to oxacillin. Results from the 
initial assessment of the differentially expressed genes that were three-fold or higher are 
summarized in Tables 4.7 and 4.8. Further analysis of the microarray data using RT-
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qPCR and validation with functional assays will help in understanding the true potential 
of msa as a target for therapy. Among other genes, major global regulators such as the 
agr system appear to be upregulated by Msa (Table 4.7) in the transcriptome analysis. 
Further studies are necessary, however, to assess the synergistic role of agr and msa in 
antibiotic resistance of Methicillin-Resistant Staphlyococcus aureus strains.  
Based on the current knowledge regarding msa, it is proposed here that Msa is 
possibly a membrane protein that regulates genes that are involved in biofilm formation, 
antibiotic resistance mechanisms and global virulence regulation (Figure 4.20). The 
multi-faceted and evidently vital role of Msa suggests that it could be an attractive 
candidate for future anti-virulence therapies against Staphylococcus aureus.  
 
 
Figure 4.20.  Msa, a putative membrane protein, is involved in regulating antibiotic 




List of Genes Downregulated in the msa Mutant in Comparison to Wild Type 
 
ORF1  Mean Gene  Gene Function 
       
SA1589 6.919 ribD riboflavin specific deaminase 
SA0029 6.567 pre plasmid recombination enzyme 
SAS066 4.883 agrD accessory gene regulator protein D 
SAS067 4.700 agrB accessory gene regulator protein B 
SA2260 4.562 fabG2 3-oxoacyl-(acyl carrier protein) reductase 
SA0040 4.436 mecI methicillin resistance regulatory protein 
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Table 4.7 (continued).  
    
ORF1 Mean Gene Gene Function 
SA1339 4.427 malR maltose operon transcriptional repressor 
SA1092 4.382 ftsZ 
cell division protein FtsZ; similar structure to tubulin; forms 
ring-shaped polymers at the site of cell division 
SA1204 4.251 trpB 
tryptophan synthase subunit beta; catalyzes the formation of L-
tryptophan from L-serine and 1-(indol-3-yl)glycerol 3-phosphate 
SAS068 4.224 agrC2 accessory gene regulator protein C 
SA0655 4.105 fruA fructose specific permease 
SA1515 4.012 phoR alkaline phosphatase synthesis sensor protein 
SA2336 3.819 clpL ATP-dependent Clp proteinase chain clpL 
SA1984 3.810 asp23 alkaline shock protein 23 
SA2428 3.738 arcA 
arginine deiminase; catalyzes the degradation of arginine to 




N-acetylmuramic acid-6-phosphate etherase; catalyzes the 
cleavage of the lactyl ether moiety of N-acetylmuramic acid-6-
phosphate (MurNAc-6-P) to form N-acetylglucosamine-6-
phosphate (GlcNAc-6-P) and lactate; MurNAc dissimilation 
pathway            
SA0041 3.521 xylR hypothetical protein; xylose repressor homologue 
SA1701 3.452 vraS two-component sensor histidine kinase 
SA0597 3.418 tagD glycerol-3-phosphate cytidylyltransferase; next to pbp4 
SA0109 3.381 sirC iron compound ABC transporter, permease protein 
   




List of Genes Upregulated in the msa Mutant in Comparison to Wild Type 
 
ORF1  Mean Gene  Gene Function 
    
SA1988 3.051 modC molybdenum transport ATP-binding protein ModC 
SA0107 3.208 spa immunoglobulin G binding protein A precursor 
SA0667 3.261 exsB ExsB protein; identified by protein match 
SA1614 3.348 menC o-succinylbenzoic acid synthetase 
SA0400 3.687 lpl4 hypothetical protein 
SA1586 3.741 ribH 6,7-diimethyl-8-ribityllumazine synthase; DMRL synthase 
SA1629 4.046 splC serine protease SplC  
SA1818 4.107   hypothetical protein; similar to beta-lactamase 
SA1372 4.229 comG ComG operon protein 3 precursor 
SA0108 4.285 sarS Staphylococcal accessory regulator S 
SA0053 4.344 radC hypothetical protein, similar to DNA repair protein 
SA0204 5.714 acpD azoreductase; cleaves azo bond in aromatic azo compounds 
MW759 9.556 sec4 enterotoxin type C precursor  
   




1. 1996. National Nosocomial Infections Surveillance (NNIS) report, data summary 
from October 1986-April 1996, issued May 1996. A report from the National 
Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 24:380-
8. 
2. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data 
summary from January 1992 through June 2004, issued October 2004. Am J 
Infect Control 32:470-85. 
3. Abdelnour, A., S. Arvidson, T. Bremell, C. Ryden, and A. Tarkowski. 1993. 
The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a 
murine arthritis model. Infect Immun 61:3879-85. 
4. Anderl, J. N., M. J. Franklin, and P. S. Stewart. 2000. Role of antibiotic 
penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin 
and ciprofloxacin. Antimicrob Agents Chemother 44:1818-24. 
5. Archer, G. L., and D. M. Niemeyer. 1994. Origin and evolution of DNA 
associated with resistance to methicillin in staphylococci. Trends Microbiol 
2:343-7. 
6. Asbell, P. A., D. F. Sahm, M. Shaw, D. C. Draghi, and N. P. Brown. 2008. 
Increasing prevalence of methicillin resistance in serious ocular infections caused 
by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract 
Surg 34:814-8. 
7. Atkinson, S., and P. Williams. 2009. Quorum sensing and social networking in 
the microbial world. J R Soc Interface 6:959-78. 
8. Bassler, B. L., M. Wright, R. E. Showalter, and M. R. Silverman. 1993. 
Intercellular signalling in Vibrio harveyi: sequence and function of genes 
regulating expression of luminescence. Mol Microbiol 9:773-86. 
9. Bayer, M. G., J. H. Heinrichs, and A. L. Cheung. 1996. The molecular 
architecture of the sar locus in Staphylococcus aureus. J Bacteriol 178:4563-70. 
10. Beenken, K. E., J. S. Blevins, and M. S. Smeltzer. 2003. Mutation of sarA in 
Staphylococcus aureus limits biofilm formation. Infect Immun 71:4206-11. 
11. Beenken, K. E., P. M. Dunman, F. McAleese, D. Macapagal, E. Murphy, S. J. 
Projan, J. S. Blevins, and M. S. Smeltzer. 2004. Global gene expression in 
Staphylococcus aureus biofilms. J Bacteriol 186:4665-84. 
12. Berger-Bachi, B., and S. Rohrer. 2002. Factors influencing methicillin 
resistance in staphylococci. Arch Microbiol 178:165-71. 
92 
 
13. Bischoff, M., P. Dunman, J. Kormanec, D. Macapagal, E. Murphy, W. 
Mounts, B. Berger-Bachi, and S. Projan. 2004. Microarray-based analysis of 
the Staphylococcus aureus sigmaB regulon. J Bacteriol 186:4085-99. 
14. Blevins, J. S., K. E. Beenken, M. O. Elasri, B. K. Hurlburt, and M. S. 
Smeltzer. 2002. Strain-dependent differences in the regulatory roles of sarA and 
agr in Staphylococcus aureus. Infect Immun 70:470-80. 
15. Blevins, J. S., A. F. Gillaspy, T. M. Rechtin, B. K. Hurlburt, and M. S. 
Smeltzer. 1999. The Staphylococcal accessory regulator (sar) represses 
transcription of the Staphylococcus aureus collagen adhesin gene (cna) in an agr-
independent manner. Mol Microbiol 33:317-26. 
16. Booth, M. C., A. L. Cheung, K. L. Hatter, B. D. Jett, M. C. Callegan, and M. 
S. Gilmore. 1997. Staphylococcal accessory regulator (sar) in conjunction with 
agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect 
Immun 65:1550-6. 
17. Bouhss, A., M. Crouvoisier, D. Blanot, and D. Mengin-Lecreulx. 2004. 
Purification and characterization of the bacterial MraY translocase catalyzing the 
first membrane step of peptidoglycan biosynthesis. J Biol Chem 279:29974-80. 
18. Brown, D. F., and D. Kothari. 1974. The reliability of methicillin sensitivity 
tests on four culture media. J Clin Pathol 27:420-6. 
19. Casiano-Colon, A., and R. E. Marquis. 1988. Role of the arginine deiminase 
system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl 
Environ Microbiol 54:1318-24. 
20. Cassat, J., P. M. Dunman, E. Murphy, S. J. Projan, K. E. Beenken, K. J. 
Palm, S. J. Yang, K. C. Rice, K. W. Bayles, and M. S. Smeltzer. 2006. 
Transcriptional profiling of a Staphylococcus aureus clinical isolate and its 
isogenic agr and sarA mutants reveals global differences in comparison to the 
laboratory strain RN6390. Microbiology 152:3075-90. 
21. Chakrabarti, S. K., and T. K. Misra. 2000. SarA represses agr operon 
expression in a purified in vitro Staphylococcus aureus transcription system. J 
Bacteriol 182:5893-7. 
22. Chan, P. F., and S. J. Foster. 1998. Role of SarA in virulence determinant 
production and environmental signal transduction in Staphylococcus aureus. J 
Bacteriol 180:6232-41. 
23. Cheung, A. L., K. J. Eberhardt, E. Chung, M. R. Yeaman, P. M. Sullam, M. 
Ramos, and A. S. Bayer. 1994. Diminished virulence of a sar-/agr- mutant of 




24. Cheung, A. L., J. M. Koomey, C. A. Butler, S. J. Projan, and V. A. Fischetti. 
1992. Regulation of exoprotein expression in Staphylococcus aureus by a locus 
(sar) distinct from agr. Proc Natl Acad Sci U S A 89:6462-6. 
25. Cheung, A. L., K. A. Nishina, M. P. Trotonda, and S. Tamber. 2008. The 
SarA protein family of Staphylococcus aureus. Int J Biochem Cell Biol 40:355-
61. 
26. Chien, Y., and A. L. Cheung. 1998. Molecular interactions between two global 
regulators, sar and agr, in Staphylococcus aureus. J Biol Chem 273:2645-52. 
27. Chien, Y., A. C. Manna, and A. L. Cheung. 1998. SarA level is a determinant 
of agr activation in Staphylococcus aureus. Mol Microbiol 30:991-1001. 
28. Chien, Y., A. C. Manna, S. J. Projan, and A. L. Cheung. 1999. SarA, a global 
regulator of virulence determinants in Staphylococcus aureus, binds to a 
conserved motif essential for sar-dependent gene regulation. J Biol Chem 
274:37169-76. 
29. Conlon, K. M., H. Humphreys, and J. P. O'Gara. 2004. Inactivations of rsbU 
and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in 
Staphylococcus epidermidis. J Bacteriol 186:6208-19. 
30. Corrigan, R. M., D. Rigby, P. Handley, and T. J. Foster. 2007. The role of 
Staphylococcus aureus surface protein SasG in adherence and biofilm formation. 
Microbiology 153:2435-46. 
31. Couto, I., H. de Lencastre, E. Severina, W. Kloos, J. A. Webster, R. J. 
Hubner, I. S. Sanches, and A. Tomasz. 1996. Ubiquitous presence of a mecA 
homologue in natural isolates of Staphylococcus sciuri. Microb Drug Resist 
2:377-91. 
32. Cramton, S., and F. Gotz. 2004. Biofilm development in Staphylococcus, p. 64-
84, Microbial Biofilms. ASM Press, Washington, DC. 
33. Cramton, S. E., M. Ulrich, F. Gotz, and G. Doring. 2001. Anaerobic conditions 
induce expression of polysaccharide intercellular adhesin in Staphylococcus 
aureus and Staphylococcus epidermidis. Infect Immun 69:4079-85. 
34. Cucarella, C., C. Solano, J. Valle, B. Amorena, I. Lasa, and J. R. Penades. 
2001. Bap, a Staphylococcus aureus surface protein involved in biofilm 
formation. J Bacteriol 183:2888-96. 
35. Cucarella, C., M. A. Tormo, C. Ubeda, M. P. Trotonda, M. Monzon, C. Peris, 
B. Amorena, I. Lasa, and J. R. Penades. 2004. Role of biofilm-associated 




36. Cunin, R., N. Glansdorff, A. Pierard, and V. Stalon. 1986. Biosynthesis and 
metabolism of arginine in bacteria. Microbiol Rev 50:314-52. 
37. Davis, J. P., P. J. Chesney, P. J. Wand, and M. LaVenture. 1980. Toxic-shock 
syndrome: epidemiologic features, recurrence, risk factors, and prevention. N 
Engl J Med 303:1429-35. 
38. de Lencastre, H., B. L. de Jonge, P. R. Matthews, and A. Tomasz. 1994. 
Molecular aspects of methicillin resistance in Staphylococcus aureus. J 
Antimicrob Chemother 33:7-24. 
39. de Lencastre, H., and A. Tomasz. 1994. Reassessment of the number of 
auxiliary genes essential for expression of high-level methicillin resistance in 
Staphylococcus aureus. Antimicrob Agents Chemother 38:2590-8. 
40. de Lencastre, H., S. W. Wu, M. G. Pinho, A. M. Ludovice, S. Filipe, S. 
Gardete, R. Sobral, S. Gill, M. Chung, and A. Tomasz. 1999. Antibiotic 
resistance as a stress response: complete sequencing of a large number of 
chromosomal loci in Staphylococcus aureus strain COL that impact on the 
expression of resistance to methicillin. Microb Drug Resist 5:163-75. 
41. Donlan, R. M., R. Murga, M. Bell, C. M. Toscano, J. H. Carr, T. J. Novicki, 
C. Zuckerman, L. C. Corey, and J. M. Miller. 2001. Protocol for detection of 
biofilms on needleless connectors attached to central venous catheters. J Clin 
Microbiol 39:750-3. 
42. Dubrovin, E. V., A. G. Voloshin, S. V. Kraevsky, T. E. Ignatyuk, S. S. 
Abramchuk, I. V. Yaminsky, and S. G. Ignatov. 2008. Atomic force 
microscopy investigation of phage infection of bacteria. Langmuir 24:13068-74. 
43. El Zoeiby, A., F. Sanschagrin, and R. C. Levesque. 2003. Structure and 
function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 
47:1-12. 
44. Fitzpatrick, F., H. Humphreys, and J. P. O'Gara. 2005. The genetics of 
staphylococcal biofilm formation--will a greater understanding of pathogenesis 
lead to better management of device-related infection? Clin Microbiol Infect 
11:967-73. 
45. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus 
aureus. Trends Microbiol 6:484-8. 
46. Fowler, V. G., Jr., J. M. Miro, B. Hoen, C. H. Cabell, E. Abrutyn, E. 
Rubinstein, G. R. Corey, D. Spelman, S. F. Bradley, B. Barsic, P. A. Pappas, 
K. J. Anstrom, D. Wray, C. Q. Fortes, I. Anguera, E. Athan, P. Jones, J. T. 
van der Meer, T. S. Elliott, D. P. Levine, and A. S. Bayer. 2005. 




47. Frees, D., A. Chastanet, S. Qazi, K. Sorensen, P. Hill, T. Msadek, and H. 
Ingmer. 2004. Clp ATPases are required for stress tolerance, intracellular 
replication and biofilm formation in Staphylococcus aureus. Mol Microbiol 
54:1445-62. 
48. Fuqua, C., and E. P. Greenberg. 1998. Cell-to-cell communication in 
Escherichia coli and Salmonella typhimurium: they may be talking, but who's 
listening? Proc Natl Acad Sci U S A 95:6571-2. 
49. Georgopapadakou, N. H., and F. Y. Liu. 1980. Penicillin-binding proteins in 
bacteria. Antimicrob Agents Chemother 18:148-57. 
50. Ghuysen, J. M., J. Lamotte-Brasseur, B. Joris, and G. D. Shockman. 1994. 
Binding site-shaped repeated sequences of bacterial wall peptidoglycan 
hydrolases. FEBS Lett 342:23-8. 
51. Gillaspy, A. F., S. G. Hickmon, R. A. Skinner, J. R. Thomas, C. L. Nelson, 
and M. S. Smeltzer. 1995. Role of the accessory gene regulator (agr) in 
pathogenesis of staphylococcal osteomyelitis. Infect Immun 63:3373-80. 
52. Gilot, P., and W. van Leeuwen. 2004. Comparative analysis of agr locus 
diversification and overall genetic variability among bovine and human 
Staphylococcus aureus isolates. J Clin Microbiol 42:1265-9. 
53. Glanzmann, P., J. Gustafson, H. Komatsuzawa, K. Ohta, and B. Berger-
Bachi. 1999. glmM operon and methicillin-resistant glmM suppressor mutants in 
Staphylococcus aureus. Antimicrob Agents Chemother 43:240-5. 
54. Goerke, C., S. Campana, M. G. Bayer, G. Doring, K. Botzenhart, and C. 
Wolz. 2000. Direct quantitative transcript analysis of the agr regulon of 
Staphylococcus aureus during human infection in comparison to the expression 
profile in vitro. Infect Immun 68:1304-11. 
55. Gorwitz, R. J., D. Kruszon-Moran, S. K. McAllister, G. McQuillan, L. K. 
McDougal, G. E. Fosheim, B. J. Jensen, G. Killgore, F. C. Tenover, and M. J. 
Kuehnert. 2008. Changes in the prevalence of nasal colonization with 
Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197:1226-34. 
56. Gotz, F. 2002. Staphylococcus and biofilms. Mol Microbiol 43:1367-78. 
57. Graham, J. E., and B. J. Wilkinson. 1992. Staphylococcus aureus 
osmoregulation: roles for choline, glycine betaine, proline, and taurine. J Bacteriol 
174:2711-6. 
58. Gustafson, J. E., and B. J. Wilkinson. 1989. Lower autolytic activity in a 
homogeneous methicillin-resistant Staphylococcus aureus strain compared to 




59. Hall-Stoodley, L., and P. Stoodley. 2009. Evolving concepts in biofilm 
infections. Cell Microbiol 11:1034-43. 
60. Handke, L. D., S. R. Slater, K. M. Conlon, S. T. O'Donnell, M. E. Olson, K. 
A. Bryant, M. E. Rupp, J. P. O'Gara, and P. D. Fey. 2007. SigmaB and SarA 
independently regulate polysaccharide intercellular adhesin production in 
Staphylococcus epidermidis. Can J Microbiol 53:82-91. 
61. Hanssen, A. M., and J. U. Ericson Sollid. 2006. SCCmec in staphylococci: 
genes on the move. FEMS Immunol Med Microbiol 46:8-20. 
62. Heilmann, C., J. Hartleib, M. S. Hussain, and G. Peters. 2005. The 
multifunctional Staphylococcus aureus autolysin aaa mediates adherence to 
immobilized fibrinogen and fibronectin. Infect Immun 73:4793-802. 
63. Heinrichs, J. H., M. G. Bayer, and A. L. Cheung. 1996. Characterization of the 
sar locus and its interaction with agr in Staphylococcus aureus. J Bacteriol 
178:418-23. 
64. Henze, U., T. Sidow, J. Wecke, H. Labischinski, and B. Berger-Bachi. 1993. 
Influence of femB on methicillin resistance and peptidoglycan metabolism in 
Staphylococcus aureus. J Bacteriol 175:1612-20. 
65. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and 
evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486-
93. 
66. Hoffman, L. R., D. A. D'Argenio, M. J. MacCoss, Z. Zhang, R. A. Jones, and 
S. I. Miller. 2005. Aminoglycoside antibiotics induce bacterial biofilm formation. 
Nature 436:1171-5. 
67. Hoiby, N., T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu. 2010. Antibiotic 
resistance of bacterial biofilms. Int J Antimicrob Agents 35:322-32. 
68. Holtje, J. V., and E. I. Tuomanen. 1991. The murein hydrolases of Escherichia 
coli: properties, functions and impact on the course of infections in vivo. J Gen 
Microbiol 137:441-54. 
69. Howden, B. P., J. K. Davies, P. D. Johnson, T. P. Stinear, and M. L. Grayson. 
Reduced vancomycin susceptibility in Staphylococcus aureus, including 
vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: 
resistance mechanisms, laboratory detection, and clinical implications. Clin 
Microbiol Rev 23:99-139. 
70. Hubscher, J., A. Jansen, O. Kotte, J. Schafer, P. A. Majcherczyk, L. G. 
Harris, G. Bierbaum, M. Heinemann, and B. Berger-Bachi. 2007. Living with 
an imperfect cell wall: compensation of femAB inactivation in Staphylococcus 
aureus. BMC Genomics 8:307. 
97 
 
71. Jacqueline, C., D. Navas, E. Batard, A. F. Miegeville, V. Le Mabecque, M. F. 
Kergueris, D. Bugnon, G. Potel, and J. Caillon. 2005. In vitro and in vivo 
synergistic activities of linezolid combined with subinhibitory concentrations of 
imipenem against methicillin-resistant Staphylococcus aureus. Antimicrob Agents 
Chemother 49:45-51. 
72. Janzon, L., and S. Arvidson. 1990. The role of the delta-lysin gene (hld) in the 
regulation of virulence genes by the accessory gene regulator (agr) in 
Staphylococcus aureus. Embo J 9:1391-9. 
73. Janzon, L., S. Lofdahl, and S. Arvidson. 1989. Identification and nucleotide 
sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator 
(agr) of Staphylococcus aureus. Mol Gen Genet 219:480-5. 
74. Jarraud, S., G. J. Lyon, A. M. Figueiredo, L. Gerard, F. Vandenesch, J. 
Etienne, T. W. Muir, and R. P. Novick. 2000. Exfoliatin-producing strains 
define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 
182:6517-22. 
75. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by 
autoinducing peptide variants. Science 276:2027-30. 
76. Katayama, Y., H. Z. Zhang, D. Hong, and H. F. Chambers. 2003. Jumping the 
barrier to beta-lactam resistance in Staphylococcus aureus. J Bacteriol 185:5465-
72. 
77. Klevens, R. M., J. R. Edwards, F. C. Tenover, L. C. McDonald, T. Horan, 
and R. Gaynes. 2006. Changes in the epidemiology of methicillin-resistant 
Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin 
Infect Dis 42:389-91. 
78. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. 
H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, 
G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. 
Invasive methicillin-resistant Staphylococcus aureus infections in the United 
States. JAMA 298:1763-71. 
79. Kock, H., U. Gerth, and M. Hecker. 2004. MurAA, catalysing the first 
committed step in peptidoglycan biosynthesis, is a target of Clp-dependent 
proteolysis in Bacillus subtilis. Mol Microbiol 51:1087-102. 
80. Kollef, M. H., A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. 
Johannes. 2005. Epidemiology and outcomes of health-care-associated 
pneumonia: results from a large US database of culture-positive pneumonia. 
Chest 128:3854-62. 
81. Kondo, Y., T. Ito, X. X. Ma, S. Watanabe, B. N. Kreiswirth, J. Etienne, and 
K. Hiramatsu. 2007. Combination of multiplex PCRs for staphylococcal cassette 
98 
 
chromosome mec type assignment: rapid identification system for mec, ccr, and 
major differences in junkyard regions. Antimicrob Agents Chemother 51:264-74. 
82. Kong, K. F., C. Vuong, and M. Otto. 2006. Staphylococcus quorum sensing in 
biofilm formation and infection. Int J Med Microbiol 296:133-9. 
83. Kopp, U., M. Roos, J. Wecke, and H. Labischinski. 1996. Staphylococcal 
peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? 
Microb Drug Resist 2:29-41. 
84. Kovacikova, G., W. Lin, and K. Skorupski. 2005. Dual regulation of genes 
involved in acetoin biosynthesis and motility/biofilm formation by the virulence 
activator AphA and the acetate-responsive LysR-type regulator AlsR in Vibrio 
cholerae. Mol Microbiol 57:420-33. 
85. Kuehnert, M. J., H. A. Hill, B. A. Kupronis, J. I. Tokars, S. L. Solomon, and 
D. B. Jernigan. 2005. Methicillin-resistant-Staphylococcus aureus 
hospitalizations, United States. Emerg Infect Dis 11:868-72. 
86. Leski, T. A., and A. Tomasz. 2005. Role of penicillin-binding protein 2 (PBP2) 
in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus 
aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J 
Bacteriol 187:1815-24. 
87. Liles, W. C., A. R. Thomsen, D. S. O'Mahony, and S. J. Klebanoff. 2001. 
Stimulation of human neutrophils and monocytes by staphylococcal phenol-
soluble modulin. J Leukoc Biol 70:96-102. 
88. Lim, Y., M. Jana, T. T. Luong, and C. Y. Lee. 2004. Control of glucose- and 
NaCl-induced biofilm formation by rbf in Staphylococcus aureus. J Bacteriol 
186:722-9. 
89. Lindsay, J. A., and S. J. Foster. 1999. Interactive regulatory pathways control 
virulence determinant production and stability in response to environmental 
conditions in Staphylococcus aureus. Mol Gen Genet 262:323-31. 
90. Liu, Y., A. C. Manna, C. H. Pan, I. A. Kriksunov, D. J. Thiel, A. L. Cheung, 
and G. Zhang. 2006. Structural and function analyses of the global regulatory 
protein SarA from Staphylococcus aureus. Proc Natl Acad Sci U S A 103:2392-7. 
91. Lovering, A. L., L. H. de Castro, D. Lim, and N. C. Strynadka. 2007. 
Structural insight into the transglycosylation step of bacterial cell-wall 
biosynthesis. Science 315:1402-5. 
92. Lowy, F. D. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-32. 
93. Mack, D., W. Fischer, A. Krokotsch, K. Leopold, R. Hartmann, H. Egge, and 
R. Laufs. 1996. The intercellular adhesin involved in biofilm accumulation of 
99 
 
Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: 
purification and structural analysis. J Bacteriol 178:175-83. 
94. Madiraju, M. V., D. P. Brunner, and B. J. Wilkinson. 1987. Effects of 
temperature, NaCl, and methicillin on penicillin-binding proteins, growth, 
peptidoglycan synthesis, and autolysis in methicillin-resistant Staphylococcus 
aureus. Antimicrob Agents Chemother 31:1727-33. 
95. Maidhof, H., B. Reinicke, P. Blumel, B. Berger-Bachi, and H. Labischinski. 
1991. femA, which encodes a factor essential for expression of methicillin 
resistance, affects glycine content of peptidoglycan in methicillin-resistant and 
methicillin-susceptible Staphylococcus aureus strains. J Bacteriol 173:3507-13. 
96. Maira-Litran, T., A. Kropec, C. Abeygunawardana, J. Joyce, G. Mark, 3rd, 
D. A. Goldmann, and G. B. Pier. 2002. Immunochemical properties of the 
staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 
70:4433-40. 
97. Manna, A. C., M. G. Bayer, and A. L. Cheung. 1998. Transcriptional analysis 
of different promoters in the sar locus in Staphylococcus aureus. J Bacteriol 
180:3828-36. 
98. Mayville, P., G. Ji, R. Beavis, H. Yang, M. Goger, R. P. Novick, and T. W. 
Muir. 1999. Structure-activity analysis of synthetic autoinducing thiolactone 
peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad 
Sci U S A 96:1218-23. 
99. McAleese, F. M., E. J. Walsh, M. Sieprawska, J. Potempa, and T. J. Foster. 
2001. Loss of clumping factor B fibrinogen binding activity by Staphylococcus 
aureus involves cessation of transcription, shedding and cleavage by 
metalloprotease. J Biol Chem 276:29969-78. 
100. McCaig, L. F., L. C. McDonald, S. Mandal, and D. B. Jernigan. 2006. 
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory 
care. Emerg Infect Dis 12:1715-23. 
101. McKenney, D., J. Hubner, E. Muller, Y. Wang, D. A. Goldmann, and G. B. 
Pier. 1998. The ica locus of Staphylococcus epidermidis encodes production of 
the capsular polysaccharide/adhesin. Infect Immun 66:4711-20. 
102. McNamara, P. J., and A. S. Bayer. 2005. A rot mutation restores parental 
virulence to an agr-null Staphylococcus aureus strain in a rabbit model of 
endocarditis. Infect Immun 73:3806-9. 
103. Memmi, G., S. R. Filipe, M. G. Pinho, Z. Fu, and A. Cheung. 2008. 
Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-
acquired methicillin-resistant strains. Antimicrob Agents Chemother 52:3955-66. 
100 
 
104. Monzon, M., C. Oteiza, J. Leiva, M. Lamata, and B. Amorena. 2002. Biofilm 
testing of Staphylococcus epidermidis clinical isolates: low performance of 
vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 44:319-
24. 
105. Morfeldt, E., D. Taylor, A. von Gabain, and S. Arvidson. 1995. Activation of 
alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense 
RNA, RNAIII. EMBO J 14:4569-77. 
106. Morfeldt, E., K. Tegmark, and S. Arvidson. 1996. Transcriptional control of 
the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. 
Mol Microbiol 21:1227-37. 
107. Nagarajan, V., and M. O. Elasri. 2007. SAMMD: Staphylococcus aureus 
microarray meta-database. BMC Genomics 8:351. 
108. Nagarajan, V., and M. O. Elasri. 2007. Structure and function predictions of the 
Msa protein in Staphylococcus aureus. BMC Bioinformatics 8 Suppl 7:S5. 
109. Naimi, T. S., K. H. LeDell, K. Como-Sabetti, S. M. Borchardt, D. J. Boxrud, 
J. Etienne, S. K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R. N. 
Danila, and R. Lynfield. 2003. Comparison of community- and health care-
associated methicillin-resistant Staphylococcus aureus infection. JAMA 
290:2976-84. 
110. Noskin, G. A., R. J. Rubin, J. J. Schentag, J. Kluytmans, E. C. Hedblom, C. 
Jacobson, M. Smulders, E. Gemmen, and M. Bharmal. 2007. National trends 
in Staphylococcus aureus infection rates: impact on economic burden and 
mortality over a 6-year period (1998-2003). Clin Infect Dis 45:1132-40. 
111. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of 
staphylococcal virulence. Mol Microbiol 48:1429-49. 
112. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. 
Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a 
regulatory RNA molecule. Embo J 12:3967-75. 
113. O'Neill, E., C. Pozzi, P. Houston, D. Smyth, H. Humphreys, D. A. Robinson, 
and J. P. O'Gara. 2007. Association between methicillin susceptibility and 
biofilm regulation in Staphylococcus aureus isolates from device-related 
infections. J Clin Microbiol 45:1379-88. 
114. Otto, M. 2009. Understanding the epidemic of community-associated MRSA and 




115. Pamp, S. J., D. Frees, S. Engelmann, M. Hecker, and H. Ingmer. 2006. Spx is 
a global effector impacting stress tolerance and biofilm formation in 
Staphylococcus aureus. J Bacteriol 188:4861-70. 
116. Patin, D., A. Boniface, A. Kovac, M. Herve, S. Dementin, H. Barreteau, D. 
Mengin-Lecreulx, and D. Blanot. 2010. Purification and biochemical 
characterization of Mur ligases from Staphylococcus aureus. Biochimie. 
117. Pereira, S. F., A. O. Henriques, M. G. Pinho, H. de Lencastre, and A. 
Tomasz. 2007. Role of PBP1 in cell division of Staphylococcus aureus. J 
Bacteriol 189:3525-31. 
118. Pinho, M. G., H. de Lencastre, and A. Tomasz. 2000. Cloning, characterization, 
and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of 
Staphylococcus aureus. J Bacteriol 182:1074-9. 
119. Projan, S. J., and R. P. Novick. 1997. The Molecular basis of pathogenicity, p. 
55-81. In G. A. a. K. Crossley (ed.), The Staphylococci in human disease. 
Churchill Livingstone, New York, N.Y. 
120. Pucci, M. J., and T. J. Dougherty. 2002. Direct quantitation of the numbers of 
individual penicillin-binding proteins per cell in Staphylococcus aureus. J 
Bacteriol 184:588-91. 
121. Qazi, S. N., C. E. Rees, K. H. Mellits, and P. J. Hill. 2001. Development of gfp 
Vectors for Expression in Listeria monocytogenes and Other Low G+C Gram 
Positive Bacteria. Microb Ecol 41:301-309. 
122. Qin, Z., X. Yang, L. Yang, J. Jiang, Y. Ou, S. Molin, and D. Qu. 2007. 
Formation and properties of in vitro biofilms of ica-negative Staphylococcus 
epidermidis clinical isolates. J Med Microbiol 56:83-93. 
123. Rechtin, T. M., A. F. Gillaspy, M. A. Schumacher, R. G. Brennan, M. S. 
Smeltzer, and B. K. Hurlburt. 1999. Characterization of the SarA virulence 
gene regulator of Staphylococcus aureus. Mol Microbiol 33:307-16. 
124. Resch, A., R. Rosenstein, C. Nerz, and F. Gotz. 2005. Differential gene 
expression profiling of Staphylococcus aureus cultivated under biofilm and 
planktonic conditions. Appl Environ Microbiol 71:2663-76. 
125. Rigoulay, C., J. M. Entenza, D. Halpern, E. Widmer, P. Moreillon, I. Poquet, 
and A. Gruss. 2005. Comparative analysis of the roles of HtrA-like surface 
proteases in two virulent Staphylococcus aureus strains. Infect Immun 73:563-72. 
126. Roche, F. M., R. Massey, S. J. Peacock, N. P. Day, L. Visai, P. Speziale, A. 
Lam, M. Pallen, and T. J. Foster. 2003. Characterization of novel LPXTG-




127. Rohde, H., E. C. Burandt, N. Siemssen, L. Frommelt, C. Burdelski, S. 
Wurster, S. Scherpe, A. P. Davies, L. G. Harris, M. A. Horstkotte, J. K. 
Knobloch, C. Ragunath, J. B. Kaplan, and D. Mack. 2007. Polysaccharide 
intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus 
epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint 
infections. Biomaterials 28:1711-20. 
128. Said-Salim, B., P. M. Dunman, F. M. McAleese, D. Macapagal, E. Murphy, 
P. J. McNamara, S. Arvidson, T. J. Foster, S. J. Projan, and B. N. 
Kreiswirth. 2003. Global regulation of Staphylococcus aureus genes by Rot. J 
Bacteriol 185:610-9. 
129. Sambanthamoorthy, K., A. Schwartz, V. Nagarajan, and M. O. Elasri. 2008. 
The Role of msa in Staphylococcus aureus Biofilm Formation. BMC Microbiol 
8:221. 
130. Sambanthamoorthy, K., M. S. Smeltzer, and M. O. Elasri. 2006. Identification 
and characterization of msa (SA1233), a gene involved in expression of SarA and 
several virulence factors in Staphylococcus aureus. Microbiology 152:2559-72. 
131. Schlesinger, L. S., S. C. Ross, and D. R. Schaberg. 1987. Staphylococcus 
aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 
66:148-56. 
132. Schofield, P. J., M. R. Edwards, J. Matthews, and J. R. Wilson. 1992. The 
pathway of arginine catabolism in Giardia intestinalis. Mol Biochem Parasitol 
51:29-36. 
133. Schrader-Fischer, G., and B. Berger-Bachi. 2001. The AbcA transporter of 
Staphylococcus aureus affects cell autolysis. Antimicrob Agents Chemother 
45:407-12. 
134. Schumacher-Perdreau, F., C. Heilmann, G. Peters, F. Gotz, and G. Pulverer. 
1994. Comparative analysis of a biofilm-forming Staphylococcus epidermidis 
strain and its adhesion-positive, accumulation-negative mutant M7. FEMS 
Microbiol Lett 117:71-8. 
135. Seidl, K., C. Goerke, C. Wolz, D. Mack, B. Berger-Bachi, and M. Bischoff. 
2008. Staphylococcus aureus CcpA affects biofilm formation. Infect Immun 
76:2044-50. 
136. Seidl, K., M. Stucki, M. Ruegg, C. Goerke, C. Wolz, L. Harris, B. Berger-
Bachi, and M. Bischoff. 2006. Staphylococcus aureus CcpA affects virulence 
determinant production and antibiotic resistance. Antimicrob Agents Chemother 
50:1183-94. 
137. Sharma, V. K., C. J. Hackbarth, T. M. Dickinson, and G. L. Archer. 1998. 
Interaction of native and mutant MecI repressors with sequences that regulate 
103 
 
mecA, the gene encoding penicillin binding protein 2a in methicillin-resistant 
staphylococci. J Bacteriol 180:2160-6. 
138. Shockman, G. D., and J. F. Barrett. 1983. Structure, function, and assembly of 
cell walls of gram-positive bacteria. Annu Rev Microbiol 37:501-27. 
139. Skov, R. L., and K. S. Jensen. 2009. Community-associated meticillin-resistant 
Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 
73:364-70. 
140. Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int 
J Med Microbiol 292:107-13. 
141. Stoodley, P., K. Sauer, D. G. Davies, and J. W. Costerton. 2002. Biofilms as 
complex differentiated communities. Annu Rev Microbiol 56:187-209. 
142. Styers, D., D. J. Sheehan, P. Hogan, and D. F. Sahm. 2006. Laboratory-based 
surveillance of current antimicrobial resistance patterns and trends among 
Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol 
Antimicrob 5:2. 
143. Toledo-Arana, A., N. Merino, M. Vergara-Irigaray, M. Debarbouille, J. R. 
Penades, and I. Lasa. 2005. Staphylococcus aureus develops an alternative, ica-
independent biofilm in the absence of the arlRS two-component system. J 
Bacteriol 187:5318-29. 
144. Tomasz, A., and S. Waks. 1975. Mechanism of action of penicillin: triggering of 
the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis. Proc Natl 
Acad Sci U S A 72:4162-6. 
145. Trotonda, M. P., S. Tamber, G. Memmi, and A. L. Cheung. 2008. MgrA 
represses biofilm formation in Staphylococcus aureus. Infect Immun 76:5645-54. 
146. Trotonda, M. P., Y. Q. Xiong, G. Memmi, A. S. Bayer, and A. L. Cheung. 
2009. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus 
autolysis and resistance to cell wall-active antibiotics. J Infect Dis 199:209-18. 
147. Truong-Bolduc, Q. C., P. M. Dunman, J. Strahilevitz, S. J. Projan, and D. C. 
Hooper. 2005. MgrA is a multiple regulator of two new efflux pumps in 
Staphylococcus aureus. J Bacteriol 187:2395-405. 
148. Tschierske, M., C. Mori, S. Rohrer, K. Ehlert, K. J. Shaw, and B. Berger-
Bachi. 1999. Identification of three additional femAB-like open reading frames in 
Staphylococcus aureus. FEMS Microbiol Lett 171:97-102. 
149. Tu Quoc, P. H., P. Genevaux, M. Pajunen, H. Savilahti, C. Georgopoulos, J. 
Schrenzel, and W. L. Kelley. 2007. Isolation and characterization of biofilm 
formation-defective mutants of Staphylococcus aureus. Infect Immun 75:1079-88. 
104 
 
150. Valle, J., A. Toledo-Arana, C. Berasain, J. M. Ghigo, B. Amorena, J. R. 
Penades, and I. Lasa. 2003. SarA and not sigmaB is essential for biofilm 
development by Staphylococcus aureus. Mol Microbiol 48:1075-87. 
151. Vuong, C., H. L. Saenz, F. Gotz, and M. Otto. 2000. Impact of the agr quorum-
sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect 
Dis 182:1688-93. 
152. Wada, A., and H. Watanabe. 1998. Penicillin-binding protein 1 of 
Staphylococcus aureus is essential for growth. J Bacteriol 180:2759-65. 
153. Wallmark, G., I. Arremark, and B. Telander. 1978. Staphylococcus 
saprophyticus: a frequent cause of acute urinary tract infection among female 
outpatients. J Infect Dis 138:791-7. 
154. Wang, R., K. R. Braughton, D. Kretschmer, T. H. Bach, S. Y. Queck, M. Li, 
A. D. Kennedy, D. W. Dorward, S. J. Klebanoff, A. Peschel, F. R. DeLeo, and 
M. Otto. 2007. Identification of novel cytolytic peptides as key virulence 
determinants for community-associated MRSA. Nat Med 13:1510-4. 
155. Weinrick, B., P. M. Dunman, F. McAleese, E. Murphy, S. J. Projan, Y. Fang, 
and R. P. Novick. 2004. Effect of mild acid on gene expression in 
Staphylococcus aureus. J Bacteriol 186:8407-23. 
156. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. 
B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis 
of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 
39:309-17. 
157. Wu, S., H. de Lencastre, and A. Tomasz. 1996. Sigma-B, a putative operon 
encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: 
molecular cloning and DNA sequencing. J Bacteriol 178:6036-42. 
158. Wyke, A. W., J. B. Ward, M. V. Hayes, and N. A. Curtis. 1981. A role in vivo 
for penicillin-binding protein-4 of Staphylococcus aureus. Eur J Biochem 
119:389-93. 
159. Yang, S. J., P. M. Dunman, S. J. Projan, and K. W. Bayles. 2006. 
Characterization of the Staphylococcus aureus CidR regulon: elucidation of a 
novel role for acetoin metabolism in cell death and lysis. Mol Microbiol 60:458-
68. 
160. Yarwood, J. M., D. J. Bartels, E. M. Volper, and E. P. Greenberg. 2004. 
Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 186:1838-50. 
161. Zhang, H. Z., C. J. Hackbarth, K. M. Chansky, and H. F. Chambers. 2001. A 
proteolytic transmembrane signaling pathway and resistance to beta-lactams in 
staphylococci. Science 291:1962-5. 
105 
 
162. Zhang, K., J. A. McClure, S. Elsayed, and J. M. Conly. 2009. Novel 
staphylococcal cassette chromosome mec type, tentatively designated type VIII, 
harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic 
strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents 
Chemother 53:531-40. 
163. Zhu, Y., E. C. Weiss, M. Otto, P. D. Fey, M. S. Smeltzer, and G. A. 
Somerville. 2007. Staphylococcus aureus biofilm metabolism and the influence 
of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, 
and pathogenesis. Infect Immun 75:4219-26. 
 
 
 
 
